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Abstract 
 
 
Background: Diabetic cataract is one of the major eye complications of diabetes. It was 
reported that cataract occurs two to five times more frequently in patients with diabetes 
compared with those with no diabetes. The purpose of this study was to identify genetic 
contributors of diabetic cataract based on a genome-wide association approach using a 
well-defined Scottish diabetic cohort. 
 
Methods: A diabetic cataract case in this study was defined as a type 2 diabetic patient 
who has ever been recorded in the linked e-health records to have cataracts in one or both 
eyes and who had previous cataract extraction surgeries in at least one eye. A control in 
this study was defined as a type 2 diabetic individual who has never been diagnosed as 
cataract in the linked e-health records and had no history of cataract surgeries. A standard 
genome-wide association approach was applied. Besides, the logistic regression was used 
to analyze the potential risk factors including Age, Gender, Body Mass Index(BMI), 
Alcohol intake, Total serum cholesterol, High-density lipoprotein(HDL)-cholesterol, 
Low-density lipoprotein(LDL)-cholesterol, Blood pressure, HbA1c and Serum 
triglycerides chosen from the literature review.  
 
Results: Overall, we have 1986 diabetic cataract cases and 3429 controls in the genetics 
of diabetes audit and research in Tayside Scotland (GoDARTS) dataset. We set the 
significant P value of Single Nucleotide Polymorphisms (SNP) in the project as 10−6, 
there are 7 associated Single Nucleotide Polymorphisms in the range of genome-wide 
significance we set, including rs10197646 (P 4.12x10-07), chr13:48026216:D (P 4.15x10-
07), rs7582173 (P 4.30x10-07), rs62168795 (P 5.59x10-07), rs1381015 (P 7.12x10-07), 
rs2269547 (P 7.25x10-07), rs523355 (P 8.63x10-07). The age-adjusted prevalence of 
diabetic cataract was 24.9% in the Tayside. We also identified age (odd ratio [OR] 0.955, 
95%confidence interval [CI] 0.948-0.962), female (OR 1.191, 95%CI 1.055-1.345), 
systolic blood pressure (OR 0.997, 95% CI 0.994-0.999) diastolic blood pressure (OR 
1.004, 95% 1.001-1.008), current smoker (OR 1.313, 95% CI 1.034-1.667), BMI in 2nd 
Quartile 27.71-31.32 (OR 0.838, 95% CI 0.703-0.998), total serum cholesterol in 2nd 
Quartile 3.92-4.37 (OR 0.798, 95% CI 0.642-0.992), serum HDL cholesterol in 3rd 
Quartile 1.36-1.48 (OR 0.737, 95% CI 0.596-0.910), and serum triglycerides in 3rd 
Quartile 2.24-2.40 (OR 0.393, 95% CI 0.316-0.490) as associated significant factors with 
diabetic cataract in Scottish population. 
 
Conclusions: We identified the 7 significant SNPs related with the potential genes in 
Tayside population and found supporting evidence that MAP3K19, R3HDM1, GGA1, 
CCT7 genes are associated with diabetic cataract. The role of genes in the 
cataractogenesis needs to be reevaluated in future studies. The risk and protective factors 
were identified with GoDARTS dataset. 
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1. Chapter 1. Introduction 
 
 
1.1. Concept of Cataract in Public Health and Epidemiology 
Public health is usually described as "the science and art of preventing disease, prolonging 
life and promoting health through organized efforts and informed choices of society, 
organizations, public and private, communities and individuals (1). The focus of public 
health is to improve the health and quality of life in human beings through the prevention 
and treatment of disease and other physical and mental health conditions. According to 
the latest reports from the World Health Organization (WHO), cataract is becoming a 
major public health concern across the world (2), is increasing in prevalence, is affecting 
quality of life, and is considered a burden on the health care system. Especially for 
diabetic patients, cataract is a major cause of blindness in developed and developing 
countries (3).  
 
In the public health field, epidemiology is the cornerstone of identifying risk factors for 
disease and targets for preventive healthcare, which develop methodology used in clinical 
research, public health studies, and even basic research in the biological sciences (4). 
With the increase in challenging health problems all over the world, genetic epidemiology, 
known as “a science which deals with the etiology, distribution, and control of disease in 
groups of relatives and with inherited causes of disease in populations”, has developed as 
one of the most important studies in recent years for determining the disease and health 
in families and populations (5). With the help of advances in genotyping technology, it is 
now feasible to conduct large-scale Genome-Wide Association Studies (GWAS) that 
genotype many thousands of single nucleotide polymorphisms (SNP) in thousands of 
individuals. These have led to the discovery of many genetic polymorphisms that 
influence the risk of developing many common diseases. As we know, there are many 
studies about cataract which focus on its distribution, determinants and risk-exposure 
associations. Moreover, genetic variants are considered as one of the determinants in 
cataract research, which now extend to a new field to explore the mechanism of diabetic 
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cataract. 
 
1.2. Concept of Cataract and Classification 
Cataract is clouding of the lens of the eye which prevents clear vision (6), it is also 
described as the opacity of crystalline lens in the eye (7). In the process of cataract 
studying, at least four systems have been developed to classify and grade lens opacities. 
These include the grading system developed at the Wilmer Ophthalmological Institute of 
Johns Hopkins University, the Oxford Clinical Cataract Classification and Grading 
System(8), the Lens Opacity Classification System (LOCS) (9), and the Wisconsin 
system(10). These involved photographic documentation of the lens, using standard 
camera and flash settings, with interpretation of the lens photographs undertaken by 
trained graders.  
 
1.3. Diagnosis 
To diagnose the cataract, detailed visual history and a full medical history should be taken, 
and the impact of cataract on the patient’s lifestyle should be evaluated. Questionnaires 
can be helpful in describing symptoms but should be used in conjunction with the 
patient’s history and examination when deciding on surgery. Following this, a complete 
ophthalmic examination should be performed by ophthalmologists (11) (Figure 1.1).  
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Figure 1.1: Stages of a full cataract examination 
  
1.4. Classification 
Cataract can be classified as nuclear, cortical or posterior by using the lens opacities 
classification system LOCS III (9). 
 
 Nuclear cataract is the most common type of cataract and involves the central or 
nuclear part of the lens; this type of cataract often results in a shift to nearsightedness 
and causes visual problems. 
 
 Cortical cataracts are due to the lens in the outer layer changing to opaque, which 
occurs in the periphery of the lens causing fissuring. These kinds of cataracts are 
detected by using an ophthalmoscope, or other magnification system, and the 
appearance is often described as the white spokes of a wheel.  
 
Visual Acuity
• Quantitative measure of the eye's ability to see an in-focus image at a certain distance 
Pupil Examination
•Pupilary function includes inspecting the pupils for equal size, regular shape, reactivity 
to light, and direct and consensual accommodation
External Eye Examination
• Including eyelids, surrounding tissues and palpebral fissure
Intraocular Pressure
•The eye is an enclosed compartment through which there is a constant circulation of 
fluid that maintains its shape and internal pressure
Slit Lamp Examination
•Examination of the anterior segment and posterior segment of the human eye, which 
includes the eyelid, sclera, conjunctiva, iris, natural crystalline lens, and cornea
Dilated Examination of the Cataract and Fundus
•Using mydriatic eye drops to dilate or enlarge the pupil in order to obtain a better view 
of the fundus of the eye
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Posterior capsular cataracts, defined as cloudy at the back of the lens adjacent to the 
capsule in which the lens sits, are due to strong light focusing on the back of the lens, 
which can cause disproportionate symptoms for their size. This type of cataract is proven 
to be the most common type in diabetic patients (12). 
 
According to previous clinical and epidemiological studies between diabetes and 
cataracts, cataract is considered a major cause of visual impairment in diabetic patients 
and the progression of cataract is elevated in patients with diabetes mellitus (13, 14). 
Diabetes mellitus is a systemic condition affecting numerous organs, including the eye, 
which has serious influence on the development and progression of ocular complications 
in diabetic patients. The International Diabetes Federation offered evidence that more 
than 285 million people suffer from diabetes mellitus worldwide; this number is expected 
to increase to 439 million by 2030 (3). Both cataract and diabetes are a big challenge in 
the public health field and the economy in developing and developed countries. As this is 
the case, it is recommended that an emphasis is put on looking for the factors that 
influence cataract in diabetic patients. 
 
1.5. The Mechanism of Cataract 
The eye, as part of our visual system, contains a lens. The lens is a clear structure behind 
the pupil and iris. The lens focuses light on the retina which is the back part of the eye 
that sends sight signals to the brain. When the lens becomes cloudy, vision blurs; we call 
this a cataract (15) (Figure 1.2).  
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Figure 1.2: Cross section of the eye 
 
The lens is an avascular organ where nutrients and oxygen are supplied by a blood-
aqueous barrier, formed by the non-pigmented layer of the epithelium of the ciliary body 
and the endothelium of the blood vessels of the iris, (16) and which depends strongly on 
glucose metabolism. Therefore, for diabetic patients, hyperglycaemia-initiated 
pathogenethy mechanisms perform an essential role in diabetes-associated changes in 
lens metabolism and cataract formation, which include, but are not limited to, increased 
aldose reductase (AR) activity, non-enzymatic glycation/glycooxidation and oxidative-
nitrosative stress (16). In fact, there have been a number of new pharmacological 
approaches supporting the breakthroughs in understanding the mechanisms of diabetic 
cataractogenesis. 
 
The process of lens glucose uptake is insulin-independent, which has different reactions 
in diabetes. Under non-diabetic conditions, glucose is phosphorylated by hexokinase and 
metabolized by glycolysis and pentose phosphate pathway. In diabetes, hexokinase has 
become saturated (17) and excesses of glucose enters the sorbitol pathway (17, 18) with 
two reactions including aldose reductase (AR) catalyses NADPH-dependent reduction of 
glucose to sorbitol and sorbitol dehydrogenase SDH catalyses NAD-dependent oxidation 
of sorbitol to fructose. Especially in diabetic cataract formation (19, 20), the increased 
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AR through the sorbitol pathway activity in the lens causes intracellular sorbitol 
accumulation, osmotic stress, and a decrease in free cytosolic NAD+/NADH+ ratio (17, 
21, 22); all consequently contribute to multiple metabolic and signal transduction changes, 
and affects transcriptional regulation and gene expression in the lens fibers and tissue 
sites for diabetic cataract (23, 24). Results of a previous animal study reported that the 
wild type Streptozotocin (STZ), when examined in diabetic mice, has a very low AR 
expression in the lens, and does not lead to sorbitol accumulation and lens opacification 
(18, 20); on the contrary, cataract developed in diabetic and galactose-fed mice expressing 
human AR in the lens (20). Furthermore, two reports demonstrated that sorbitol 
accumulation and the rate of cataractogenesis were greater in diabetic AR expressing 
mice (25, 26). All of this evidence indicates that increased AR activity plays a key role in 
diabetic cataract formation. Recent studies have shown the increased AR activity is likely 
to influence the development of diabetic cataract through osmotic stress. An extensive 
research in the crystalline lens by Kinoshita (21) suggests that osmotic stress is important 
in the development of fast cataractogesis in young diabetic and galactose-fed animal 
models. However, the increased AR activity might have greater important influence on 
slow cataract development in mature STZ-diabetic rats treated with insulin (27, 28) and 
diabetic patients. Although the AR activity in the human lens is rather low (29), it is 
unknown exactly how much of the enzyme is necessary to produce a detrimental 
metabolic consequence that includes cataract. Still, the important role of AR in the 
progress of diabetic cataract in humans has been proven by a genetic study of cataract 
risk factors in Hong Kong Chinese patients (30). 
 
Non-enzymatic glycation and glycoxidation have important implications in the 
pathogenesis of diabetic complications (16). The test found advanced glycation end 
products (AGE) in the process of non-enzymatic glycation and glycoxidation accumulate 
in the lenses of some types of diabetic animals, as well as cataractous lenses in diabetic 
patients (31). The AGE formation often occurs in both lens epithelial (32) and ﬁber cells 
(33-35), and the AGE-modiﬁed β- and γ-crystallins have been detected in strepotozotocin 
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diabetic rats (34, 35). Similarly, the AGE accumulation has also been identified in 
cataractous lenses in humans with diabetes (36, 37). The AGE accumulation contributes 
to the human lens protein aggregation and subsequent insolubilzation (38), where the high 
and low molecular weight crystallins andα-crystallin from diabetic displayed elevated 
furosine content (36), and the AGE-linked autofluorescence has been reported to an 
increase in cataractous lenses of diabetic subjects when compared with the non-diabetic 
controls (37). Moreover, the modification of α-crystallin caused multiple changes in lens 
including structural changes, cross-linking, coloration and subsequent insolubilization 
leading to a scatter of light (39). Moreover, a follow-up study demonstrated the 
modification of α-crystallin might cause unfolding and decreased stability leading to 
enhanced proteolysis in the human lens (39). All of these studies tend to support the 
influence of AGE accumulation during Non-enzymatic glycation and glycoxidation on 
the development of diabetic cataract. At the same time, there are other experimental and 
clinical studies reporting that an inhibitor of AGE in diabetic rats was ineffective in 
preventing fast cataractogenesis (40). Although a number of researches and studies have 
shown the important influence of Non-enzymatic glycation and glycoxidation with AGE 
accumulation on the pathogenesis of diabetic cataract, it is still a subject of controversy. 
 
What is more, in several diabetic complications, the oxidative–nitrosative stress was 
recognized as a key mechanism in the pathogenesis (17). Oxidative stress presents in the 
early stages of diabetes in the lens, and is manifested by the accumulation of lipid 
peroxidation products, reduced glutathione (GSH) and other metabolites. Oxidative-
nitrosative stress also causes an interaction with multiple mechanisms including increased 
AR activity, non-enzymatic glycation and glycoxidation, and elevation of cytosolic Ca 
2+; which together have influences on the development of diabetic cataract (41). Using 
transgenic mice that over express aldose reductase (AR) in their lenses, studies have 
found that the flux of glucose through the polyol pathway is the major cause of 
hyperglycemic oxidative stress in this tissue (42). AR reduction of glucose to sorbitol 
probably contributes to oxidative stress by depleting its cofactor NADPH, which is also 
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required for the regeneration of GSH. Sorbitol dehydrogenase, the second enzyme in the 
polyol pathway that converts sorbitol to fructose (19, 20), also contributes to oxidative 
stress, most likely because depletion of its cofactor NAD+ leads to more glucose being 
channeled through the polyol pathway. There are few studies presenting clear evidence 
of complete correction of oxidative stress-nitrosative mechanism in diabetic cataract 
patients (43, 44), where chronic oxidative stress generated by the polyol pathway is likely 
to be an important contributing factor in the slow-developing diabetic cataract, as well as 
in the development of other diabetic complications (42). 
 
1.6. Genetic Factors about Diabetic Cataract 
Based on genetic epidemiology, Genome-Wide Association Studies (GWAS) can be used 
to compare the DNA of participants having varying phenotypes for a particular disease. 
Participants in a GWAS study are treated as cases and controls. This approach is known 
as phenotype-first, in which the participants are classified first by their clinical 
manifestations, as opposed to genotype-first. Each person gives a sample of DNA, from 
which millions of genetic variants are read using SNP arrays. If one type of the variant 
(one allele) is more frequent in people with the disease, the variant is said to be associated 
with the disease. The associated SNPs are then considered to mark a region of the human 
genome that may influence the risk of disease (45, 46).  
 
1.6.1. Genetic Variants in Cataract 
Understanding the genetic factors related to the diabetic cataract would assist in 
identifying the potential causal mechanisms for future researches. Animal models have 
been widely applied in genetic research in cataracts. A small scale Genome-Wide 
Associated Study (GWAS) proposed 15 loci genome related to diabetic cataract in the 
Chinese population; the loci of which contain candidate genes of PPARD, CCDC102A, 
GBA3, NEDD9, GABRR1/2, RPS6KA2, tcag7.1163, TAC1, GALNTL1 and KIAA1671 
(47). These candidates involved the relative mechanisms of cataract formation, and 
GWAS is considered as a useful and efficient method to identify potential candidate genes 
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for common complex disorders using DNA chips (48). The DNA chips can genotype 
thousands of single nucleotide polymorphisms (SNP) in individuals to compare variants 
between cases and controls. 
 
1.6.2. Genetic Variants in Diabetes 
Genome-Wide Association Studies have ascertained these genetic variants to be 
associated with an increased risk of diabetes. These studies concluded the Transcription 
Factor 7-like 2 (TCF7L2) has the strongest susceptibility effect (49), which had an 
influence on the development of Type 2 diabetes via its role in the development of 
pancreatic islet cells including beta-cell survival and secretory function; development of 
myocytes and adipocytes. Also, other genes discovered from the GWAS include HHEX 
controlling beta islet cell development; WFS1 is responsible for the survival and function 
of the beta islet cells; SLC30A8 affects insulin production and secretion through the 
transport of zinc to the pancreatic beta islet cells; GIPR is associated with reducing beta 
cell function; KCNJ11 blocks the release of serum glucose to cells, and IGF2BP2 is linked 
to increased adipose levels and insulin resistance.  
 
1.7. Epidemiological Risk Factors for Cataract 
The development of cataract is a complex process affected by multiple risk factors. To 
understand this better, the association between risk factors and cataract have to be 
explored. Therefore, the following table concluded the potential risk factors which could 
affect the development of diabetic cataract according to the previous studies and 
researches (Table 1.1). 
 
1.7.1. Personal Characteristics 
a) Age  
Epidemiological studies on lens opacities mostly focus on age-related cataract; the 
development of cataract is a continuous process and some opacification occurs 
systematically with age (50). In the UK, there are a number of population based studies 
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for prevalence of cataract. According to the North London Eye Study data, the prevalence 
of visually impairing cataract rose steadily with age: 16% in the 65 to 69 year age group, 
24% in people 70 to 74 years of age, 42% in those 75 to 79 years of age, 59% in those 80 
to 84 years, and 71% in people aged 85 years old or over (51). Another study, The Lens 
Opacities Case-Control Study, explored the risk factors for age-related nuclear, cortical, 
posterior subcapsular and mixed cataracts, and showed cortical cataracts were associated 
with age with relative risk (RR) = 11.4 for age 70 years compared to age 50 years, nuclear 
cataracts have 38.6 times more risk of developing in those aged 70 years when compared 
to those aged 50 years (52). Even taking gender into consideration, the prevalence of 
cataract is still significantly associated with increasing age, the increase is 3-fold for 
males and approximately double for females between the ages of 60-64 years and 75 years 
and older, as shown in a Nepalese blindness survey (53). Similarly, an American Health 
and Nutrition Examination Survey showed the prevalence of cataract in a group aged 45-
64 years is three times higher than that for the 65-75 year age group, for both females and 
males (54). Therefore, age is a major risk factor in the development of cataract. 
 
b) Gender 
If taking adjustment for other risk factors, women would commonly show a higher 
cataract prevalence when compared to men (50). Many studies worldwide have reported 
a higher prevalence of cataract among women (55, 56), although in some studies this 
varied by the type of opacity (57, 58). The Blue Mountains Eye study released in Australia 
showed 53.3% of cataract prevalence for women and 49.7% for men in moderate or 
advanced nuclear opacities. The cortical cataract was present in 25.9% of women and 
21.1% of men, and posterior subcapsular cataract was less frequent (59); which is 
consistent with three other studies. The estimate of age-adjusted prevalence in the United 
States for women was significantly higher than men (55), and in a case-control study to 
find the risk factor for lens opacity females had a higher prevalence than males in the 
different cataract classification groups (60). What is more, a longitudinal study also 
confirmed the higher relative risk of lens opacity in women when compared with men 
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(61). 
 
c) Race 
The influence of the human race on development of cataract is still controversial in many 
studies. The Singapore Epidemiology of Eye Diseases Study concluded different Asian 
ethnicities had a higher prevalence and earlier age of onset of cataract than Europeans 
(62). The Baltimore Eye Survey stated cataract accounted for 27% of blindness among 
blacks, among whom it was four times more common than among whites, and whites 
were almost 50% more likely than blacks to have cataract extraction (63). The results 
from a Longitudinal Study of Cataract show the 2.94 attributable risk in increased nuclear 
opacification for whites (61). On the other hand, the National Health and Nutrition 
Examination Survey found the cortical cataracts had 3.5 relative risk (RR) in those of 
black race when compared with those of white race (52). 
 
d) Social Economics and Education 
A number of studies have identified the social economic status and level of education as 
important risk factors for cataract, where multivariate analyses demonstrated that 
cataracts were more severe when the median income was lower and unemployment rate 
was higher (64). However, they are probably confounded by factors that were omitted or 
that are not yet understood. Therefore, a case-control study of cataract risk factors has 
now been performed to support that low education and no education were associated with 
an increased risk of cataract after adjustment for age and other demographics factors (65). 
Another case-control confirmed that education and income were associated with age-
standardized cataract prevalence for certain Asian subgroups (62). 
 
1.7.2. Medical History 
a) Diabetes 
Diabetes was strongly associated with the risk of all types of cataract. Biochemical studies 
of cataractous lenses in those with diabetes and galactosemia showed abnormalities in the 
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levels of electrolytes, glutathione, glucose or galactose (66); which can lead to 
hyperosmotic effects in the lens such as lens fiber swelling, vacuole formation and 
opacification (14, 66). A number of epidemiological studies have supported this 
significant association between cataract and diabetes. The Framingham Eye Study 
observed the association of increasing blood sugar level with cataract (14), and several 
clinic-based studies have also found diabetes to be a risk factor for cataract (67-69). A 
population-based study, conducted in South Central Wisconsin, identified the important 
characteristics for diabetic cataract patients; for younger-on-set diabetics, the most 
important factor was increasing duration of diabetes, for older-onset diabetics it was age 
at the time of the survey. The National Health and Nutrition Examination Survey analyzed 
a three- to four-fold excess risk of senile cataracts for diabetic individuals younger than 
65 years old, but the risk did not persist for those over 65 years of age with the 
Framingham data (70). 
 
b) Smoking 
For smoking, evidence shows a causal relationship between cigarette smoking and 
cataract (71), which has also been demonstrated by study testing the dose-effect 
relationship between a pack of cigarettes smoked and the opacification degree, and also 
shows that increased duration of smoking is related to the risk of cataract (72, 73). The 
literature reviews suggest a strong association between the development of nuclear 
cataract and smoking, but there is limited evidence for the risk of cortical and posterior 
subcapsular cataract (74). Smoking may cause damage to the lens by increasing oxidative 
stress, by lowering levels of circulating antioxidants or by increasing lens cadmium levels 
(75-77). 
 
c) Ultraviolet Radiation 
Lens opacification has been related to ocular exposure to ultraviolet radiation, particularly 
ultraviolet B (UV-B), because the lens has the ability to absorb UV-B and UV-A (78). The 
animal experiments claimed that the changes in lens clarity were related to different 
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intensity exposures and chronic exposure to UV-B (79); these findings have also been 
addressed in several epidemiological studies. For example, the National Trachoma and 
Eye Health Programme in Australia revealed a dose-response relationship of increasing 
prevalence of cataract with increasing levels of ultraviolet B radiation (80). In Nepal, 
another national survey found a positive correlation between cataract prevalence and 
average daily sunlight hours (81). In some areas of Nepal, there is a daily average of 12 
hours of sun exposure which results in a prevalence of cataract nearly four times higher 
than those living with seven hours of exposure. In the United States, the National Health 
and Nutrition Examination survey analyzed data from almost 10,000 eye examinations in 
35 geographic locations to conclude that people living with higher total annual sunshine 
hours had a higher prevalence of cataract (82).  
 
d) Blood Pressure/Hypertension 
In the Framingham Eye Study, systolic blood pressure was significantly higher in those 
with cataract when compared to non-cataract individuals in the same age and sex groups 
(14). A National Health and Nutrition Examination Survey showed a twice increased risk 
for having Posterior subcapsular cataract in those with systolic blood pressure of 160 
mmHg compared to those with 120 mmHg (52). The documented case-control study 
between India and the U.S. suggested an increased risk for nuclear and mixed cataracts 
for each 20 mmHg increase in systolic blood pressure (83). However, the reason for blood 
pressure potentially affecting cataract development is still unclear, and more studies are 
needed to find the accurate mechanism by examining the independent effects of blood 
pressure and use of antihypertensive medications (84, 85). There was an investigation 
which showed that cataract could be prevented by both acute and chronic dietary sodium 
restriction on genetically hypertensive, salt-sensitive rats; suggesting a stronger role for 
extracellular fluid volume status than that of sustained arterial hypertension in cataract 
development (86). 
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1.7.3. Biochemical Variables 
Previous experimental studies determined the lipid composition in protein fractions of 
human lens and senile cataracts (87), suggesting cholesterol is the major lipid component 
of the ocular lens (88), and the increased risk of senile cataracts related to 
cholesterol/phospholipid ratio (87). Some epidemiological studies report the different 
levels of total serum cholesterol, LDL cholesterol and HDL cholesterol are related to the 
cataract (89, 90). Also, experimental research has found some inhibitors of cholesterol 
can block cholesterol accumulation by these lenses and can produce cataracts in dogs (91), 
moreover, patients using cholesterol-lowering statin drugs may be at an increased risk of 
developing age-related cataracts (92). Based on the updated literature review, plasma 
retinol level was recognized as a significant risk factor for nuclear and mixed cataracts, 
as well as cataract surgery, which strongly suggest that vitamin A may be a protective for 
cataract (93, 94). Two other studies on plasma retinol (95, 96) gave inconsistent results; 
the cataract retinol relation could be confounded possibly by plasma carotenoid, which 
may decrease the risk of cataracts severe enough to require extraction (97).  
 
Indeed, apart from serum cholesterol and Vitamin A, Serum triglycerides, HbA1c and 
urinary protein, all have some kind of influence on the progress of cataract (98). 
 
Previously, one of researches to quantitatively evaluate the prevalence and risk factors of 
cataracts in Korean patients with type 2 diabetes mellitus discussed the risk factors like 
sex, age, duration of diabetes, fasting blood sugar, HbA1c, creatinine, and total 
cholesterol between patients with and without cataracts. Moreover, another cross-
sectional study used the LOCS III to classify the cataract as different subtypes, and 
revealed that the age- and sex-adjusted prevalence of cataract in the study was 65.7% (95% 
CI, 65.6-65.8). Mixed cataracts were more common than monotype ones (41.6% vs. 
19.4%). The prevalence of cataract was higher in women, subjects with known diabetes 
and those with longer duration of diabetes (51.4%, 50.3%, and 64.5%, respectively). The 
risk factors for any type of cataract were increasing age (OR, 1.14; 95% CI, 1.11-1.16). 
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Therefore, we concluded the table 1.1 to demonstrate the potential risk factors for the 
diabetic cataract from recent studies.    
 
Table 1.1: Risk factors for cataract 
 
 
1.8. Epidemiology of Cataract  
Cataract epidemiology is becoming an intensive research. Over the last decades, several 
large population based studies have offered new results on the prevalence of cataract in 
many regions, which has become more meaningful as more attention is directed to 
improving the assessment and measurement of both cataract and the potential risk factors. 
The reports for the estimate of blindness and visual impairment in 2010 show there are 
285 million affected by visual impairment or blindness. According to data from the WHO, 
cataract is the leading cause of visual impairment (33%) and blindness (41%) (99).  
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1.8.1. The Epidemiology of Cataract in Asia 
As the world’s largest continent, with more than half of the world’s population, up to 20 
million Asians are estimated to be blind by the WHO (100). However, the prevalence of 
cataract between studies varies widely, and the comparison is confounded by differing 
population characteristics and diagnostic methods of lens opacity. Mostly based on the 
clinical examination Lens Opacity Classification III (LOCS III), the Tanjion Pagar Survey 
showed the prevalence of cataract for people over 40 years in Singapore is 34.7% (101), 
compared with a cataract prevalence of 61.9% in Indian people from the same age group 
in the Araind Eye Study (57). Shihpai Eye Study for Taiwan people over 65 years 
demonstrated the prevalence of 59.2% (102), and the Sumatra Eye Study in Indonesia 
offered 23.0% people suffering from cataract (103). However, there are few data on 
cataract surgery rates in Asia. The WHO suggested that an annual rate of 350 surgeries 
per 100,000 is a useful target to tackle the burden of cataract blindness (104); this 
threshold may have been achieved in some Asian countries (105). 
 
1.8.2. The Epidemiology of Cataract in America 
Institutes in the United States have conducted many population studies and have more 
accurate data for cataract. According to cataract reports from the National Eye Institute 
in 2010 (106), white Americans aged 40 and older had the highest prevalence rate of 
cataract (18%) followed by black Americans (13%); Hispanic Americans had the lowest 
rate of cataract (12%). Among all people with cataract in the U.S., the vast majority were 
white (80%) with lower rates for black people (8%) and Hispanic people (7%). Cataract 
also varied by gender, 61% of Americans with cataract were women with 39% being men. 
This report also indicated that the number of people in the U.S. with cataract is expected 
to double from 24.4 million to approximately 50 million. The majority of cases will affect 
white people; however Hispanic Americans are expected to have the most rapid increase 
in prevalence from 1.76 million cases to 9.51 million.  
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1.8.3. The Epidemiology of Cataract in Europe 
The crude prevalence of cataract in European adults in 2007 was 19.3%. The presented 
prevalence rates highlight the impact cataract has on the population in Europe. Based on 
a previous review, the highest crude prevalence of cataract in adults was estimated to be 
in Germany (0.20 per 100,000 person-years) followed by Italy (0.065 per 100,000 person-
years) and then the European North of Russia (0.039 per 100,000 person-years) (107). As 
for the UK, the North London Eye Study showed a steadily increasing prevalence of 
cataract in different age groups: 16% in the 65 to 69 year age group, 24% in people of 70 
to 74 years of age, 42% in those 75 to 79 years of age, 59% in those 80 to 84 years and 
71% in people aged 85 years or more. It was estimated that 225,000 new cases of visually 
impairing cataract should be expected each year, the 5-year cumulative incidence being 
estimated at 1.1 million new cases among the population aged 65 years and older (51).  
 
1.9. Prevention, Treatment and Care Pathway of Cataract 
Although many advances in recent years have been made to identify the risk factors for 
cataract, there are no medical treatments proven to reverse, or even slow down, the 
progress of cataract (51). A number of studies suggest certain nutrients and nutritional 
supplements may reduce the risk of cataracts. One large, 10-year study of female health 
professionals found that higher dietary intakes of vitamin E and the carotenoids lutein and 
zeaxanthin from food and supplements were associated with significantly decreased risks 
of cataract (97). Other studies have shown that antioxidant vitamins such as vitamin C 
and foods containing omega-3 fatty acids, may reduce cataract risk (93, 94). Another 
method to reduce your risk of cataracts is to wear protective sunglasses blocking the suns 
UV rays when you are outdoors (108). These possible preventive measures have not been 
conclusively demonstrated to work and may be of limited use in a well-nourished 
population from a country with a temperate climate.  
 
Surgery seems to be the only effective treatment to restore or maintain vision for cataract 
patients. Phacoemulsification is the most common technique used in developed countries. 
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The internal lens is emulsified with an ultrasonic hand piece and aspirated from the eye, 
then an intraocular lens implant (IOL) is placed into the remaining lens capsule (109). 
Intracapsular cataract extraction (ICCE) is carried out to remove the entire lens including 
its capsule. The procedure has a relatively high rate of complications due to the large 
incision required and pressure placed on the vitreous body. In countries where operating 
microscopes are available, this technique has been superseded by extra capsular cataract 
extraction (ECCE) where the nucleus and cortex are removed through the anterior capsule, 
leaving the posterior capsule in place, which produces faster visual rehabilitation and 
fewer complications (110).  
 
Every year approximately 10 million cataract operations are carried out in the world. In 
a Cataract Surgery Statistics study, the cataract surgery rate in India has approximately 
doubled in the last 10 years to around 3,000 operations per million populations per year 
now. In the most developing countries of Asia, the current cataract surgical rate is between 
500 and 1,500, and in many countries of Africa the rate is less than 500. For Western 
Europe, the cataract surgery rate is 4,000, and in North America the cataract surgery rate 
remained at 5,500 (111).  
 
Figure 3 provides a brief process of the care pathway for cataract patients within the 
National Health Service (NHS) (124). Cataract management is a multi-professional 
process involving ophthalmologists, optometrists, nurses and technicians. The 
ophthalmologist should take the responsibility for diagnosis and management of the 
patient. The decision on whether to proceed to surgery should be made by the patient in 
discussion with an ophthalmologist. Cataract surgery should be performed by an 
ophthalmic surgeon while much of the process may be undertaken by the non-medical 
members of the team provided that they are properly trained and supervised (11).
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Figure 1.3: Process of the care pathway within the NHS 
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2. Chapter 2. Methodology 
 
 
2.1. Study Setting and Design 
2.1.1. Introduction of Genetics of Diabetes Audit and Research Tayside (GoDARTs) 
dataset 
The Genetics of Diabetes Audit and Research Tayside (GoDARTS) project was originally 
created to record and analyze the risk factors for diabetes and its complications. This is 
an international biomedical and genetic resource for the study of type 2 diabetes and 
related conditions. It is estimated that there are now over 180 million people worldwide 
with diabetes. This chronic disease can cause serious health problems including heart 
disease, blindness, kidney failure and amputation. A high quality resource, initially 
funded by the Wellcome Trust and supported by Diabetes UK, has been created with 
successful recruitment of consenting patients with type 2 diabetes and matching controls 
(non-diabetics) throughout Tayside. This resource is already available to researchers 
worldwide and is helping to define genetic factors related to diabetes including 
susceptibility, complications and response to treatment. This international resource will 
become more powerful with time and will benefit from continual collection and the fast 
pace of technological progress in the field of genetic research. The response from the 
Tayside population has been exceptional and volunteers have participated in clinics, GP 
surgeries and work places throughout the region, and the project has now started 
recruiting in Fife. The participants consent to a baseline measurement-link to data 
gathered and anonymous follow up through datasets derived from medical records. 
 
2.1.2. GoDARTS Data Collection 
Every individual was required to complete a lifestyle questionnaire, a baseline clinical 
examination, and offer the biological samples when they came into the group. With their 
permission, the researchers would have access to their health information and biological 
samples for the study and a link to the private information the NHS medical records hold. 
A detailed history record, including demographics, prescribing history, general practice 
clinic visits, hospital admissions and outpatient appointments, was obtained at the base 
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hospital and was then linked with the Scottish Care Information-Diabetes Collaboration 
(SCI-DC) database; SCI-DC was commissioned and is owned by the Scottish 
Government. Every patient has a tracked electronic health record system and receives the 
care in Scotland.  
 
2.2. Date Source and Participants 
2.2.1. Case and Control Definition  
The GoDARTS project has over 9,000 patients with type 2 diabetes and over 8,000 age-
matched controls in the Tayside region of Scotland. For our project, we recruited 9,439 
type 2 diabetic patients originally. Based on our project, the diabetic cataract case was 
defined as a type 2 diabetic patient recorded in the linked e-health records as having 
cataract in one eye at least or having previous cataract extraction surgeries in one eye at 
least. In fact, cataract appears more often in a mixed format mentioned above combining 
nuclear cataract, cortical cataract or posterior subcapsular cataract, than a single entity in 
clinical settings. It was reported that around one in three cataracts are a mixed type in a 
diabetic population (47). Therefore, the case used in our study was clearly described as 
any cataract. The control was defined as a type 2 diabetic patient who had never been 
diagnosed with cataract in the e-health records and had no history of cataract surgeries. 
We extracted the missing individuals and incomplete data. After filtering, there were 
1,986 cases and 3,429 controls left for our project analysis. For the case and controls, 
individuals were chosen from the original database and we extracted the cataract 
individuals from all eye problems, and these cataract individuals were divided into people 
with cataract and people with cataract extraction. For the first group, they were cataract 
present, cataract absent, cataract present unknown eye and absent unknown. For the 
second extraction group, they were extraction and extraction eye unknown. Obviously, if 
we put these data into our regression model without filtration, it would be complex. 
Therefore, according to the case and control definition, after extraction and combination, 
there was a new variable; Diabetic cataract type containing two groups, which were 
diabetic cataract patient tagging as 1, and non-diabetic cataract patient tagging as 2. 
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2.2.2. GWAS Data Collection and Handling 
The project GoDARTS adapted two types of DNA chips to genotype its diabetic 
individuals. The Affymetrix SNP6.0 chips were funded by the Wellcome Trust Case 
Control Consortium 2 (WTCCC2) project (112), and the Illumina OmniExpress chips 
were funded by the Surrogate markers for Micro- and Macro-vascular hard endpoints for 
Innovative diabetes Tools (SUMMIT) project (113). Genotype data quality controls were 
based on the standard protocols that were established for the WTCCC2 studies (112) and 
the SUMMIT studies (113). 
 
2.2.3. Epidemiological Variables Collection and Handling 
According to the literature review, important factors are required to find whether there is 
significant association between the potential risk factors and diabetic cataract, and to 
demonstrate an epidemiological result in the Tayside population. These variables for 
epidemiology analysis were also chosen from the original GoDARTs dataset.  
 
Demographic Factors 
Age:  Age is the most common cause (114): lens proteins denature and degrade over 
time, and this process is accelerated by diabetes mellitus. In a previous study, the 
increasing age group is associated with a higher prevalence of cataract (98). 
 
Gender:  The combined evidence from the National Health And Nutrition Examination 
Survey (NHANES) follow-up study shows the excess risk for females to develop cataract 
(52). In a population-based prevalence survey in Beaver Dam, Wisconsin, women had 
more cortical opacities compared to men within similar age groups (115).  
 
BMI: Body Mass Index (BMI) is a simple index of weight-for-height that is commonly 
used to classify underweight, overweight and obesity in adults. It is defined as the weight 
in kilograms divided by the square of the height in meters (kg/m2) (116).  
 
Smoking status: From literature review, there are about 8 studies (73, 117, 118) that have 
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shown the association between increased risk of lens opacity and smoking.  
 
Alcohol: UK government alcohol guidelines state that men and women are advised not 
to regularly drink more than 14 units per week. One unit equals 10ml or 8g of pure alcohol, 
which is around the amount of alcohol the average adult can process in an hour. This 
means that within an hour there should be, in theory, little or no alcohol left in the blood 
of an adult, although this will vary from person to person (119). 
 
Economic status: We used the Scottish index of multiple deprivation (SIMD) to 
demonstrate the economic status of the studied population (120). It was a deprivation 
score based on the relative ranking within certain areas from most deprived to least 
deprived. In this study, Quintile SIMD includes five levels: “most deprived”, “deprived”, 
“middle”, “affluent” and “most affluent”. 
 
Biochemistry Factors 
We selected the total serum cholesterol (mmol/L), serum HDL cholesterol (mmol/L), 
serum LDL cholesterol (mmol/L), HbA1c m%, serum triglycerides (mmol/L) and blood 
pressure, which are divided into Diastole (mmHg) and Systole (mmHg), from 
biochemistry tests. In fact, we chose urine creatinine as one of the variables at the 
beginning, however there was more than 20% missing data that would influence the 
results; hence it was decided to exclude it.  
 
2.3. Statistics Analysis  
2.3.1. GWAS Statistics 
The Linux software including Putty and WinSCP were used to deal with the original gene 
data. We collected the genotyped SNPs from Affymetrix and Illumina chips. Standard 
quality control steps such as exclusion of participants with more than 5% missing 
genotype data, SNPs with missing genotype of more than 5%, SNPs with less than 1% 
minor allele frequency and SNPs that failed Hardy–Weinberg tests (P<0.000001) were 
applied during data analysis using PLINK, which is the primary software for data 
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manipulation (121). SNPs on sex chromosomes and mitochondria were also excluded. P 
values were calculated by the logistic regression tests integrated in PLINK and P value 
of less than 10-6 was considered to be statistically significant. Based on the principle of 
GWAS, the P value is one of the key parameters to test the significance of association in 
the study. In fact, the exact threshold of P value varies by study, but the conventional 
threshold is 5×10−8 to be significant in the face of hundreds of thousands to millions of 
tested SNPs (121). Although the genome-wide significance P value threshold of 5 × 10−8 
has become a standard for common-variant GWAS, it has not been updated to cope with 
the lower allele frequency, which means, in many GWAS studies where there is not 
enough population size to get more significant test value, we still are allowed to use wider 
P value instead (47). At the same time, the P value is not the only testing value in GWAS, 
we could also find the OR for each SNP in the studied population to find the significant 
association (45). 
 
When obtaining the SNPs logistic results, we used the Haploview software to create the 
Manhattan plot, which displayed the 22 chromosomes on the X axis, and negative 
logarithm of the P-value for each SNP on the Y axis; each dot in the plot represents a SNP 
in this population. The strongest associations have the smallest P-values, and their 
negative logarithms will be the greatest. Additionally, we compared the frequency of 
related SNPs in our project with the 1000 Genome Project to recommend the dominant 
allele in each SNP.   
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Figure 2.1: Workflow of the methodology for this GWAS on diabetic cataract using GoDARTS database. 
 
2.3.2. Epidemiological Statistics 
We put all variables into univariable and multivariable regression models to find the 
significant value for each variable. IBM SPSS software version 22 was used with 
regression models in analysis to find the association between potential risk factors and 
diabetic cataract. The X2 test was used to test the difference of sex frequency between 
cases and controls and an independent t-test was used for other variables that were 
presented as mean ± standard deviation (Table 3.3). 
 
There are six demographic variables including age, gender, BMI, smoking status, alcohol 
intake and SIMD. There are six biochemistry factors including Serum cholesterol, HDL-
cholesterol, LDL-cholesterol, Blood pressure (diastolic and systolic), HbA1c and 
Triglycerides. All of these 12 variables were divided into continuous factors and 
categorical factors.  
 
The categorical factors were classified as different levels and labeled in SPSS. For gender, 
1 meant males and 2 meant females. For SIMD, 0 meant missing data, 1 represented the 
most affluent people, 2 represented affluent, 3 represented middle, 4 represented deprived, 
and 5 represented the most deprived people. For smoking status, 0 was unknown status, 
1
• Studied individuals were genotyped using Affymetrix SNP6.0 and 
Illumina OmniExpress
2
• Extract imputed genotypes of cases and controls according to 
definitions
4
• Merge, detect population stratification, remove relatives and 
perform routine quality control
5
• Obtain cleaned datasets including 1,986 cases and 3,249
controls in PLINK format 
6
• Logistic regression analyses in PLINK 
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1 was current smoker, 2 was ex-smoker, and 3 were people who had never smoked.  
 
As for continuous variables, the normality test was used to check their normality 
respectively. For a better regression analysis, age, BMI, alcohol intake, total serum 
cholesterol, HDL-cholesterol, LDL-cholesterol, systolic pressure, diastolic pressure, 
HbA1c and serum triglycerides were transferred to a different variable with new 
classification. In a previous study (98), the variables were graded with quintiles; similarly, 
we classified these continuous variables with quartiles considering the sample size of our 
study, which could give us a clear classification and understanding about the relation 
between these factors and diabetic cataract. We used the 25%, 50% and 75% quartile to 
classify them into four groups; these new categorical variables were then put into our 
regression model. The alcohol intake was divided into two parts with 14 points because, 
based on the UK NHS guideline (119), men and women are advised not to regularly drink 
more than 14 units a week to reduce the risk of harming health (NHS live well). Therefore, 
1 meant alcohol intake less than 14 units per week and 2 meant alcohol intake more than 
14 units per week. We then put all variables into the univariable regression and 
multivariable regression models.  
 
The univariable regression was used to test the association between the diabetic cataract 
and each potential risk factor, which is easy to understand. Moreover, we’d like to use 
multiple logistic regression when having one nominal and two or more measurement 
variables. The nominal variable is the dependent (diabetic cataract) variable; we are 
studying the effect that the independent (risk factors) variables have on the probability of 
obtaining a particular value of the dependent variable. The multiple logistic regression is 
to find an equation that best predicts the probability of a value of the Y variable as a 
function of the X variables we chose. Whether the purpose of a multiple logistic 
regression is prediction or understanding functional relationships, we usually want to 
decide which variables are important and which are unimportant, we can use an objective 
method (forward selection, backward elimination, or stepwise), or we can use a careful 
examination of the data and understanding of the biology to subjectively choose the best 
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variables. So we discussed the risk factors about their association in previous studies to 
decide which variable can be analyzed in the regression.  
 
In the PLINK logistic regression, we used the Odds Ratio to describe the risk of potential 
SNP to the diabetic cataract in studied population. The GWAS also compare the 
association between SNPs and rare disease, which is more accurate than other parameters. 
Besides, in epidemiology statistics, logistic regression is one way to generalize the OR 
beyond two binary variables. And in our study, the OR is to quantify how strongly the 
presence or absence of the selected factor is associated with the presence or absence of 
the reference factor in a given population. The variables were classified as different levels 
and one level was chosen as reference. If the OR is greater than 1, the selected factor 
could rise the risk of developing the cataract compared with reference factor. On the 
contrary, if the OR is less than 1, the factor could reduce the risk of developing the cataract, 
which can be recognized as protective factor.  
 
Otherwise, the relative risk (RR) is often used to express the association among the factors 
in cohort study. Both the OR and RR compare the likelihood of an event between two 
groups. However, our study is kind of case-control study, we wouldn’t choose the RR as 
the parameter, because, the RR measures events in a way that is interpretable and 
consistent with the way people really think. The RR, though, cannot always be computed 
in a research design. Also, the RR can sometimes lead to ambiguous and confusing 
situations.    
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3. Chapter 3. Results 
 
 
3.1. Genetic Related Results 
In this general diabetic cataract study of the Scottish population with GoDARTs, we 
identified 1,986 type 2 diabetic patients with cataract and 3,429 controls without cataract 
according to the linked e-health records after removing type 1 diabetic patients and 
patients with no genetic data. After filtrating, there were approximately 60,000 SNPs 
selected in this project to be analyzed by GWAS. Table 3.1 demonstrates all the significant 
SNPs from the smallest to largest in this population, whose significant value are less than 
10-6.  
 
The most significant SNP is rs10197646 with P value of 4.12x10-7 (OR: 1.617, 95%CI: 
1.343 1.948), which locates in the Chromosome 2. The next SNP is chr13: 48026216: D 
locating in Chromosome 13, this SNP has the second smallest P value of 4.15x10-7 (OR: 
2.187, 95%: 1.615 2.961), but its OR is higher than other significant SNPs’. The 
rs62168795 (OR: 1.626, 95%CI: 1.342 1.947) and rs62168795 (OR: 1.416, 95%CI: 1.260 
1.698) have a P value of 4.30x10-7 and 5.59x10-7, respectively, which are all in the 
Chromosome 2. The P value of rs1381015 in Chromosome 4 dramatically increases to 
7.12x10-7 when compared with the last SNPs, however the OR is the smallest among them 
(OR: 1.420, 95%CI: 1.236 1.630). Then, the rs2269547 in Chromosome 2 is close to the 
rs1381015 with the P value of 7.25x10-7 (OR: 1.809, 95%CI: 1.431 2.288). The last SNP 
is rs523355 (OR: 2.149, 95%CI: 1.585 2.915) with the largest P value of 8.63x10-7 and 
the largest OR among these 7 significant SNPs.  
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Table 3.1: Significant SNPs in the population 
 
 
Table 3.2 shows the frequency of these 7 significant SNPs’ dominant allele in case and 
control. All the SNP locate in the 2 allele. The frequency of dominant allele of rs10197646 
is 0.1374 in case and 0.0940 in control (OR: 1.536). For chr13:48026216: D, the allele 
frequency in case (0.0548) is almost twice larger than that in control (0.0286), however, 
both of them are smallest among all alleles. The frequency of allele of rs7582173 in case 
is the same as that of rs10197646, but the frequency in control is slightly higher than that 
of rs10197646. As for rs62168795, its frequency in case and control are stable, being 
close to 20%. For rs1381015, both frequencies are more than 20%; moreover, the 
frequency in case is close to 30%. The SNP rs2269547 has a frequency of dominant allele 
of 0.1135 in case and 0.0668 in control. The last significant SNP has the highest OR, and 
the frequency in case and control are similar to the chr13:48026216:D.  
 
The frequencies of all seven alleles (Table 3.2) in all case are higher than those in control, 
and the highest frequency in case and control for these alleles are all concentrating on the 
middle range. The frequency of each allele increases steadily, peaking at 0.2916 in case 
and 0.23300, then falls suddenly to the bottom. At the same time, the frequency of the 
most significant SNP’s allele is slightly higher than the last significant SNP’s allele, where 
there is no great difference between them.  
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Table 3.2: The Frequency of Allele in Case and Control 
 
 
The Manhattan plot of the GWAS for this project illustrates all associated SNPs 
genotyped in Affymetrix chips and Illumina chips from 1,986 cases and 3,429 controls in 
this project, which displays 22 chromosomes on X-axis with different colors, and negative 
logarithm of the P value for each SNP on Y-axis, where each dot in the plot represents a 
SNP in this population. As we know, the strongest associations have the smallest P values, 
and their negative logarithms will be the greatest. Since we set the significant value as 10-
6 in this project, the seven significant SNPs mentioned in Figure 3.1 are above the red line 
and other insignificant ones are under it.  
 
This plot (Figure 3.1) provides us a clear observation of the distribution of each SNP 
excluding ones with P<0.01 in the Manhattan plot of GWAS. There are seven SNPs 
reaching the GWAS significance (P< 10-6). In the Chromosome 2, there are four SNPs, 
which are rs10197646, rs7582173, rs62168795 and rs523355; the smallest significant 
SNP and largest significant SNP are both located in this Chromosome. The rs10197646 
and rs7582173 are too close to put together in the plot as they appear to be one dot. Other 
significant SNPs are located in Chromosome 4, 13 and 22, respectively.  
 
As we can see, the majority of the P value of SNPs in the population are distributed from 
10-2 to 10-4.5, although there are some separate dots in the range between 10-5 and 10-6 
close to the significant line.  
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Figure 3.1: The Manhattan plot of the GWAS on diabetic cataract (1986 cases and 3429 controls) SNPs with P < 0.01 were excluded. The red line represents a P value of 10-6 in the plot.
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3.2. Epidemiology Related Results 
 
Table 3.3: Baseline Characteristics of Study Population 
 Non-Cataract (3429)  Any Cataract (1986)  
 Mean± SD  
or N (%) 
95% CI  Mean± SD   
or N (%) 
95% CI P 
Age 66.45±9.82 66.12-66.78  70.01± 8.41 69.64-71.97 <0.001 
Gender      0.0025 
Male 1879 (54.8) 52.5-57.0  986 (49.6) 46.5-52.7  
Female 1549 (45.2) 42.7-47.6  1000 (50.4) 47.3-53.5  
BMI 31.27±5.50 31.0-31.4  30.64±4.70 30.4-32.6 0.002 
Smoking       
Current smoker 314 (15.8) 11.7-19.8  346 (10.1) 6.9-13.3  
Ex-smoker 667 (33.6) 30.0-37.1  1348 (39.3) 36.7-41.9  
Never smoker 997(50.5) 47.4-53.6  1732 (50.5) 48.2-52.9  
Alcohol intake       
<14 per week 3407 (99.4) 99.1-99.6  1982 (99.8) 99.6-100  
≥14 per week 22 (0.6) 0.1-3.8  4 (0.2) 0.1-4.6  
SIMD       
Most deprived 1013 (29.6) 26.7-32.4  442 (22.3) 18.4226.2  
Deprived 658 (19.2) 16.1-22.2  374 (28.3) 23.7-32.9  
Middle 446 (13) 9.8-16.1  303 (15.3) 11.3-19.4  
Affluent 724 (32.1) 28.7-35.5  516 (26) 22.2-29.8  
Most affluent 534 (15.6) 12.5-18.7  319 (16) 11.9-20.2  
Total serum Cholesterol, 
mmol/L 
4.37±0.84 4.34-4.40  4.34±0.76 4.31-6.31 <0.001 
Serum triglycerides, 
mmol/L 
2.25±1.32 2.21-2.30  2.15±0.99 2.11-4.11 0.196 
Serum HDL cholesterol, 
mmol/L 
1.36±0.36 1.35-1.37  1.39±0.35 1.37-3.35 <0.001 
Serum LDL cholesterol, 
mmol/L 
2.05±0.65 2.03-2.08  2.03±0.59 2.01-3.99 0.04 
HbA1c mg% 7.65±1.40 7.60-7.69  7.56±1.27 7.51-9.52  
Blood pressure      <0.001 
Systole 136.92±29.88 135.92-137.92  139.23±30.83 137.87-140.58 <0.001 
Diastole 73.10±20.34 72.42-73.79  71.68±20.66 70.77-73.64 0.002 
       
 
Besides the genetic variants results, we also want to demonstrate some basic 
understanding of the epidemiological reports for the studied population to provide more 
additional demographic information in order to describe our population better. 
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Table 3.3 presents the baseline characteristics of the study population between non-
cataract group (n=3,429) and any cataract group (n=1,986). Firstly, we should compare 
the difference of continuous variables between the non-cataract group and any cataract 
group. The average age of non-cataract people (66.45, 95%CI: 66.12-66.78) is younger 
than those with cataract (70.01, 95%CI: 69.64-71.97), however the standard deviation is 
higher than the cataract populations. Compared with the WHO BMI definition, the BMI 
results in our study show that the controls we chose had a slightly higher BMI average 
than cases, and its 95%CI range is smaller than that for cases. As for the biological test 
results containing total serum cholesterol, serum triglycerides, serum HDL cholesterol, 
serum LDL cholesterol, HbA1c and blood pressure, which are the keys factors in the 
health records in the GoDARTs, we might conclude that the average of these variables in 
the non-cataract population are all higher than those of any cataract population except for 
systolic blood pressure and serum HDL cholesterol. 
 
The average of total serum cholesterol in controls is 0.03 bigger than that of cases (4.37 
mmol/L vs. 4.34 mmol/L). The control groups serum triglycerides mean value is 0.1 
higher than that of case group (2.25 mmol/L vs. 2.15 mmol/L). For serum HDL 
cholesterol and serum LDL cholesterol, the trend is opposite between the two groups. The 
HDL cholesterol in non-cataract population is lower than that in any cataract population 
(1.36 mmol/L vs. 1.39 mmol/L), but its standard deviation is larger in comparison (0.36 
vs. 0.35). On the other hand, the average and standard deviation of LDL cholesterol in 
controls are both higher than those in cases. According to classification of blood pressure 
for adults ("Understanding blood pressure readings", American Heart Association), the 
desired blood pressure range is 90–119 mmHg for systolic blood pressure, and 60–79 
mmHg for diastolic blood pressure. Back to our study, for the controls group, the blood 
pressure is 136.92 mmHg (Systole) (95%CI: 135.92 137.92) and 73.10 mmHg (Diastole) 
(95%CI: 72.42 73.79). Then any cataract people in our study hold the higher systolic 
blood pressure at 139.23 mmHg (95%CI: 137.87 140.58), and lower diastolic blood 
pressure at 71.68 mmHg (95%CI: 70.77 73.64). The categorical variables are shown with 
classification tables and charts below, which can provide more detail about the population 
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characteristics.   
 
3.2.1. Age and Diabetic Cataract Prevalence 
For better analysis, we transferred the age from the continuous variable to the categorical 
variable. According to Scotland’s Census in 2011 from the Scottish government (122), 
the whole population was divided into multiple groups: 0-4 years old, 5-15 years old, 16-
29 years old, 30-44 years old, 45-59 years old, 60-74 years old and 75 years old and over. 
However, in our studied population, the people were divided into four groups because the 
individuals are all over 30 years old (Figure 3.2). 
 
 
Figure 3.2: Percentage for each age group in the Non-cataract and Any Cataract groups 
 
In the first group (30-44 years old), there are 89 patients without cataract and 15 cataract 
patients, where the occupation of controls (2.6%) is three times more than that of cases 
(0.8%), however both are the smallest in the Non-cataract group and Any cataract group. 
In the second group, between 45 and 59, the number of non-cataract patients rise to 645 
occupying 18.8% of all controls. Meanwhile, the cases increase steadily and only take up 
7.0% of cases population. In our studied population, most of the people are aged between 
60 to 74 years old (almost 60% of the population in controls and cases groups (controls: 
2,017, cases: 1,269)); although this age group is not the biggest part of the Scottish 
population census in 2011 (122). Then, for the last group, the number of non-cataract 
patients over 75 years old falls to a similar percentage (18.0) as the 45-59 group, and the 
cataract patients account for 28.3% of all cases in last age group. 
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3.2.2. Gender 
 
Figure 3.3: Percentage for gender in the Non-cataract and Any Cataract groups 
 
When comparing the differences between males and females in our studied population, 
firstly we demonstrate the number and percentage of male and female in the control and 
case groups. In the control group, the percentage of males is almost 10% higher than that 
for females. On the contrary, the number of male and female patients in the cataract group 
is similar; the pie chart also shows that the percentage is almost 50% for each (Figure 3.3).  
 
Table 3.4: Prevalence of diabetic cataract in male and female 
 
Cataract N n % 95% CI RR 
Male 2865 986 34.4 32.7-36.1 1 
Female 2549 1000 39.2 37.3-41.1 1.14 
 
Secondly, we found the prevalence of diabetic cataract between males and females. The 
list above (Table 3.4) shows the number of males (2,865) and females (2,549) in this study 
are similar. For the male group, the number of cataract patients is 986, accounting for 
34.4% (95% CI: 32.7-36.1). The female cataract patients total 1,000 in the group with 
39.2 % (37.3-41.1) cataract prevalence. Therefore, in this study, the cataract prevalence 
in females is a little higher than the prevelance in males, and the female group has the 
relative risk of 1.14 compared with the male group. 
36 
 
 
 
Table 3.5: Prevalence and age-adjusted prevalence in the Any Cataract and Non-cataract groups 
  Prevalence  Age-Adjusted Prevalence 
Cataract N % 95%CI  % 95%CI 
Any Cataract 1986 36.7% 34.6-38.8  24.9% 23.0-26.8 
Non-Cataract 3429 63.3% 61.7-64.9  75.1% 73.7-76.5 
Total 5415 100   100  
*Age adjusted to population of Tayside, based on census of Scotland Health Board Area 2011 
 
The main epidemiological result in this project is demonstrated in Table 3.5 and shows 
the diabetic cataract prevalence is 36.7% in this population, and we used the Scotland 
health census age distribution to calculate the age-adjusted prevalence of 24.9%, which 
is lower (Table 3.5). The prevalence of each subtypes are not provided due to the lack of 
data in the initial health records. 
 
3.2.3. Smoking Status and Alcohol  
 
Figure 3.4: Percentage for each smoking status group in the Non-cataract and Any Cataract groups  
 
The chart (Figure 3.4) above show the basic information regarding the smoking status of 
the population. As we can see, the group of never smokers is the main section in both the 
Non-cataract (50.51%) and any cataract groups (50.52%). The smallest section is for 
those of unknown status. For the current smokers, the people in the Non-cataract group 
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are 32 more than that in the any cataract group, but the percentage in Non-cataract people 
(10.1%) is higher than in the any cataract group (15.8%). For the Ex-smokers, the Non-
cataract people total 1,348 accounting for 39.3%, which is the second largest section in 
the group. Meanwhile, any cataract people total 667 and occupy 33.9% in this group, 
which is half less than the amount of people in the non-cataract group, but slightly less 
than the percentage in it. 
 
Table 3.6: Differences for alcohol intake in the Non-cataract and Any Cataract groups 
 
 
 
 
 
 
 
According the UK government alcohol intake guideline, the whole population was 
divided into two parts, and the vast majority of people have an alcohol intake lower than 
14 unit per week in Non-cataract and Any cataract people (Table 3.6). 
 
3.2.4. Scottish Index of Multiple Deprivation (SIMD) 
 
Figure 3.5: Percentage for SIMD in the Non-cataract and Any Cataract groups 
 
 Non-Cataract  Any Cataract 
Alcohol N %  N % 
<14 per week 3407 99.4  1982 99.8 
≥14 per week 22 0.6  4 0.2 
Total 3429 100  1986 100 
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We can see that the Scottish Index of Multiple Deprivation classification was divided into 
five levels. For these five groups, the number of people in the non-cataract group is higher 
than the any cataract group. However, in the non-cataract population, 29.5% people 
belong to the most deprived group, which is the largest section. Next, the deprived and 
affluent groups have a similar percentage of people (19.2% and 21.1%, respectively), then 
the most affluent and middle group only have 15.6% and 13.0% people, respectively. In 
the any cataract group, the largest section belongs to the affluent group with 26.0% 
cataract individuals, and the most deprived group still has the most cataract people 
(22.3%). The distribution in the deprived (18.8%) and most affluent groups (16.1%) are 
stable between non-cataract and any cataract group. Finally, the middle group is still the 
smallest group with 15.3%. Finally, we could ignore the unknown groups, which are only 
1.6% in both cases and controls (Figure 3.5). 
 
3.2.5. Biological Test  
 
Table 3.7: Total serum cholesterol distribution in the Non-cataract and Any Cataract groups 
 
All continuous variables were classified into four groups with quantiles. For total serum 
cholesterol, the first (26.8%) and last groups (27.3%) have the most non-cataract people, 
on the contrary, in the cataract population, the middle groups (32.4% and 24.6%) account 
for the majority. Obviously, the distribution of non-cataract people increases with the rise 
of total serum cholesterol from second part peaking, but amount of any cataract people 
decreases with the rise of total serum cholesterol at the same point (Table 3.7).  
 Non-Cataract  Any Cataract 
Total Serum Cholesterol mmol/L N %  N % 
1st Quartile (<3.92) 921 26.8  445 22.4 
2nd Quartile (3.92-4.37)  730 21.3  643 32.4 
3rd Quartile(4.38-4.65) 842 24.6  488 24.6 
4th Quartile (>4.65) 936 27.3  410 20.6 
Total 1986 100  3429 100 
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Table 3.8: Serum HDL cholesterol distribution in the Non-cataract and Any Cataract groups 
 
If we look at the HDL cholesterol, the distribution of people is extremely imbalanced in 
the non-cataract population. There are 1,146 individuals (33.4%) in the second group but 
only 450 (13.1%) in the third group, and in the any cataract population, the distribution 
is similar in all groups except for the second (601, 30.3%). In surprise, the number of non-
cataract people is much more than that of any cataract in the first, second, and fourth 
groups, but less than that in the third (Table 3.8).   
 
Table 3.9: Serum LDL cholesterol distribution in the Non-cataract and Any Cataract groups 
 
As for serum LDL cholesterol (Table 3.9, 错误!未找到引用源。), the number of non-
cataract (1,402) and any cataract people (1,007) peak at the highest point in the second 
group, moreover half percent of any cataract people are in this group. There are only 195 
non-cataract individuals (5.7%) and 94 any cataract individuals (4.7%) in the third group, 
 Non-Cataract  Any Cataract 
Serum HDL Cholesterol mmol/L N %  N % 
1st Quartile (<1.16) 966 28.2  434 21.8 
2nd Quartile (1.17-1.35) 1146 33.4  601 30.3 
3rd Quartile (1.36-1.48) 450 13.1  494 24.9 
4th Quartile (>1.48) 867 25.3  457 23.0 
Total 1986 100  3429 100 
 Non-Cataract  Any Cataract 
Serum LDL Cholesterol  mmol/L   N %  N % 
1st Quartile (<1.72) 900 26.2  464 23.4 
2nd Quartile (1.73-2.09) 1402 40.9  1007 50.7 
3rd Quartile (2.10-2.22) 195 5.7  94 4.7 
4th Quartile (>2.22) 932 27.2  421 21.2 
Total 1986 100  3429 100 
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which are the smallest of the whole population. For the other two groups, the numbers of 
non-cataract people (900, 932) are almost twice that of any cataract people (464, 
421,Table 3.9).    
 
Table 3.10: BMI distribution in the Non-cataract and Any Cataract groups 
 
The BMI results show a stable distribution of studied people in all four BMI groups. In 
the Non-cataract group, the number of people decreases from 893 in the first group to 751 
in the third group, but it eventually rises to 961 in the last group. For the any cataract 
group, the highest number (691) is in the second group and it dramatically falls down to 
385 in the last group (Table 3.10).    
 
Table 3.11: HbA1c distribution in the Non-cataract and Any Cataract groups 
 
 
 
 
 
 
 
 
 
For HbA1c distribution, most of the people are located in the lower levels, 28.5% of 
controls in the first group and 32.1% of controls in the second group, while 24.8% of 
 Non-Cataract  Any Cataract 
BMI N %  N % 
1st Quartile(<27.70) 893 26.0  478 24.1 
2nd Quartile(27.71-31.32) 824 24.0  691 34.8 
3rd Quartile(31.33-32.70) 751 21.9  432 21.8 
4th Quartile(>32.70) 961 28.0  385 19.4 
Total 1986 100  3429 100 
 Non-Cataract  Any Cataract 
HbA1c mg% N %  N % 
1st Quartile (<6.80) 976 28.5  493 24.8 
2nd Quartile (6.81-7.50) 1099 32.1  893 45.0 
3rd Quartile (7.51-8.00) 443 12.9  201 10.1 
4th Quartile (>8.00) 911 26.6  399 20.1 
Total 1986 100  3429 100 
41 
 
 
cases in the first group and 45.0% of cases in the second group. The lowest number for 
both groups is in the third HbA1c group, 443, 12.9% and 201, 10.1%, respectively (Table 
3.11, 错误!未找到引用源。).  
 
Table 3.12: Triglycerides distribution in the Non-cataract and Any Cataract Groups 
 
In the serum triglycerides distribution table, the percentage of non-cataract population in 
all groups except the third group are similar (26.0%, 27.4%, 28.1%), the lowest point is 
18.5% at the third group. For the any cataract population, the highest percentage is 34.6% 
at the third group, while in the other three groups, this trend decreases with the rise of the 
triglycerides level (Table 3.12).    
 
Table 3.13: Blood Pressure shown for Systolic and Diastolic for the Non-cataract and Any Cataract Groups 
 
 Non-Cataract  Any Cataract 
Serum Triglycerides mmol/L N %  N % 
1st Quartile (<1.50) 893 26.0  479 24.1 
2nd Quartile (1.51-2.23) 939 27.4  437 22.0 
3rd Quartile (2.24-2.40) 633 18.5  688 34.6 
4th Quartile (>2.41) 964 28.1  382 19.2 
Total 1986 100  3429 100 
  Non-Cataract  Any Cataract 
Systolic Blood Pressure mmHg  N %  N % 
1st Quartile (<126)  901 26.4  450 22.7 
2nd Quartile (127-140)  1032 30.1  569 28.7 
3rd Quartile (141-152)  684 19.9  432 21.8 
4th Quartile (>152)  809 23.6  535 26.9 
       
Diastolic Blood Pressure mmHg       
1st Quartile (<68)  873 25.5  548 27.6 
2nd Quartile (69-76)  838 24.4  528 22.6 
3rd Quartile (77-83)  849 24.8  468 23.6 
4th Quartile (>84)  869 25.3  442 22.3 
42 
 
 
Table 3.13 above illustrates the distribution of cases and controls with blood pressure, 
which is classified as systolic pressure and diastolic pressure (Table 3.13). 
 
For the systolic pressure group, the largest percentage of controls is 30.1% in the second 
group, where the distribution of cases is also the largest (28.7%). The distribution in the 
other groups is similar. For the diastolic pressure group, the percentage in each group is 
similar for both cases and controls. 
 
 
Figure 3.6: Comparison of systolic and diastolic pressure in the Non-cataract group 
 
 
Figure 3.7: Comparison of systolic and diastolic pressure in the Any Cataract group 
 
When comparing the systolic pressure and diastolic pressure together, it is clear that most 
of the controls have higher systolic pressure, and the people in diastolic pressure group is 
likely to be distributed equally, the amount of each part is around 800. At the same time, 
in the cases population, the number of cases in the diastolic pressure group goes up 
steadily from 442 to 548, while the number of cases in the systolic pressure group 
43 
 
 
fluctuates. In fact, the largest group is at the third part, and the smallest group belongs to 
the second part. In conclusion, the distribution of cases and controls in diastolic pressure 
are all more stable than that in systolic pressure (Figure 3.6, Figure 3.7). 
 
3.2.6. Regression 
Table 3.14 is the summery tables which include the results of the univariate analysis and 
multivariate analysis of all variables. The analysis was performed to identify risk factors 
and protective factors for diabetic cataract in our study population.  
 
In the initial univariate analysis, the significant factors are age (P<0.001), gender 
(P=0.001), current smoker (P<0.001), alcohol intake (P=0.018), SIMD (P<0.001) and 
BMI (P<0.001). For biochemistry factors, the significant factors are pressure (Systole 
P=0.007, Diastole P=0.014), Total serum cholesterol (P<0.001), HDL serum cholesterol 
(P<0.001), LDL serum cholesterol (P<0.001), serum triglycerides (P<0.001) and HbA1c 
(P<0.001). The univariate analysis regression only shows the association with a single 
variable, where other cofounders and bias are excluded, which might affect the final 
significant association. Therefore, the results for every variable in the multivariate 
regression model could tell us better and give more understanding about the association 
between these factors and diabetic cataract. 
 
In the multivariate regression table, age is significantly associated with diabetic cataract 
(P<0.001), and the odd ratio suggests that age is a protective factor to the diabetic cataract 
(OR: 0.955 95%CI: 0.948 0.962). In gender, being female is a possible risk factor related 
to the development of diabetic cataract (P=0.005, OR: 1.191, 95%CI: 1.055 1.345). In 
smoking status, current smokers are likely to have a higher risk of developing diabetic 
cataract (P=0.025, OR: 1.313 95%CI: 1.034 1.667), and non-smokers are also related to 
the diabetic cataract (P=0.048) as a risk factor. However, there is no evidence showing 
the relationship between ex-smokers and diabetic cataract. 
 
Although SIMD is associated with diabetic cataract in univariate regression, the five 
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classifications with P value over 0.05 are not related to the diabetic cataract. Additionally, 
the most deprived group (OR: 1.171, 95%CI 0.733 1.871) and deprived group (OR: 1.010, 
95%CI: 0.629 1.620) seem to have the risk for the diabetic cataract, but their 95% 
confidence interval with 1 cannot support the suggestion. Similarly, the odd ratio of 
affluent groups cannot prove the prevention for the development of diabetic cataract to 
some degree. Then, BMI factor is a significant factor for diabetic cataract. The first 
(P=0.183) and third (P=0.056) range are not significantly related to the cataract, but the 
second range (P=0.048, OR: 0.838, 95%CI: 0.703 0.998) is likely to be the protective 
factor for the progression of cataract.  
 
When we come to the biochemical factors, total cholesterol serum, HDL serum 
cholesterol, Serum triglycerides and blood pressure are significantly associated with 
diabetic cataract in this regression model. In the total serum cholesterol groups, the lower 
serum cholesterol is a protective factor that might prevent the progression of diabetic 
cataract (2nd range, OR: 0.798, 95%CI: 0.642 0.992). The higher serum cholesterol 
ranges have no obvious relation to the cataract. In the HDL serum cholesterol groups, the 
higher range is strongly associated with diabetic cataract (3rd range, OR: 0.972, 95%CI: 
0.723 1.307), which is also a protective factor for cataract; the higher serum triglycerides 
is strongly associated with the prevention of developing cataract in this population 
(P<0.001, OR: 0.393, 95%CI: 0.316 0.490). In blood pressure groups, the systolic blood 
pressure (P=0.003) and diastolic blood pressure (P=0.007) are both significant with 
diabetic cataract, moreover, systole is a protective factor in the study (OR: 0.997, 95%CI: 
0.994 0.999), but diastole possibly increases the progression of diabetic cataract (OR: 
1.004, 95%CI: 1.001 1.008). 
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Table 3.14: Risk factors for diabetic cataract in the regression analysis 
 
Univariate Analysis 
 
Multivariate Analysis  
 
OR 95% CI P OR 95% CI P 
Age 0.959 0.953-0.965 <0.001 0.955 0.948-0.962 <0.001 
Gender Female 1.230 1.101-1.374 0.005 1.191 1.055-1.345 0.005 
Blood Pressure       
Systole 0.997 0.996-0.999 0.007 0.997 0.994-0.999 0.003 
Diastole 1.003 1.001-1.006 0.014 1.004 1.001-1.008 0.007 
Smoking Status 
    
  
Current smoker 1.444 1.154-1.807 0.001 1.313 1.034-1.667 0.025 
Ex-smoker 1.030 0.889-1.193 0.695 1.081 0.925-1.264 0.328 
Never smoker 1.147 0.990-1.330 0.069 1.172 1.002-1.372 0.048 
Unknown (ref)       
Alcohol Intake       
<14 per week 0.234 0.070-0.784 0.018 0.318 0.091-1.110 0.073 
≥14 per week (ref)       
BMI (kg/m2) 
     
 
1st Quartile <27.70 0.748 0.636-0.880 <0.001 1.133 0.943-1.361 0.183 
2nd Quartile 27.71-31.32  0.478 0.409-0.558 <0.001 0.838 0.703-0.998 0.048 
3rd Quartile 31.33-32.70 0.696 0.589-0.823 <0.001 1.238 0.995-1.541 0.056 
4th Quartile >32.70 (ref) 
  
   
SIMD       
Most deprived 1.358 0.865-2.133 <0.001 1.171 0.733-1.871 0.510 
Deprived 1.043 0.661-1.644 <0.001 1.010 0.629-1.620 0.969 
Middle 0.872 0.550-1.383 <0.001 0.834 0.516-1.346 0.457 
Affluent 0.831 0.529-1.306 <0.001 0.842 0.527-1.348 0.475 
Most affluent 0.992 0.627-1.569 <0.001 0.995 0.617-1.603 0.982 
Total Serum Cholesterol, mmol/L 
    
  
1st Quartile <3.92 0.907 0.771-1.066 <0.001 1.114 0.833-1.489 0.468 
2nd Quartile 3.92-4.37 0.497 0.425-0.582 <0.001 0.798 0.642-0.992 0.042 
3rd Quartile 4.38-4.65 0.756 0.643-0.888 <0.001 1.049 0.844-1.305 0.664 
4th Quartile >4.65 (ref)       
Serum HDL Cholesterol, mmol/L 
    
  
1st Quartile <1.16 1.173 1.000-1.377 <0.001 0.897 0.728-1.107 0.311 
2nd Quartile 1.17-1.35 1.005 0.865-1.168 <0.001 1.145 0.942-1.391 0.175 
3rd Quartile 1.36-1.48 0.480 0.405-0.570 <0.001 0.737 0.596-0.910 0.005 
4th Quartile >1.48 (ref)   
 
   
Serum LDL Cholesterol, mmol/L 
 
 
 
   
1st Quartile <1.72 0.876 0.746-1.029 <0.001 0.930 0.709-1.220 0.600 
2nd Quartile 1.73-2.09 0.629 0.546-0.724 <0.001 0.856 0.700-1.048 0.132 
3rd Quartile 2.10-2.22 0.937 0.714-1.230 <0.001 0.972 0.723-1.307 0.852 
4th Quartile >2.22 (ref)   
 
   
HbA1c mg%  
  
   
1st Quartile <6.80 0.867 0.739-1.017 <0.001 1.035 0.872-1.229 0.692 
2nd Quartile 6.81-7.50 0.539 0.465-0.624 <0.001 0.888 0.745-1.058 0.182 
3rd Quartile 7.51-8.00 0.965 0.787-1.184 0.734 1.110 0.894-1.379 0.343 
4th Quartile >8.00 (ref)       
Serum Triglycerides mmol/L 
     
 
1st Quartile <1.50 0.739 0.628-0.869 <0.001 0.814 0.656-1.012 0.063 
2nd Quartile 1.51-2.23 0.851 0.723-1.003 0.055 0.938 0.775-1.135 0.508 
3rd Quartile 2.24-2.40 0.365 0.311-0.428 <0.001 0.393 0.316-0.490 <0.001 
4th Quartile >2.41 (ref)       
       
Significant results are shown in bold front (p<0.05).  
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4. Chapter 4. Discussion 
 
 
4.1. Genetic Variants Discussion 
In our studies, we performed a GWAS on diabetic cataract using a Scottish diabetic cohort 
based on phenotype information from linked e-health records and genetic information 
from DNA chips. All diabetic patients in Scotland attend retinal screening annually. 
During the screening, whether patients have cataracts or not will be determined by 
clinicians. However, when recording the case of a diagnosis of a cataract, they do not 
report the specific subtype of the cataract or the severity of the cataract. As we learned 
from background reading, the cataract appears more often in a mixed format (a 
combination of nuclear cataract, cortical cataract or posterior subcapsular cataract) rather 
than a single entity in clinics (123). Therefore, the phenotype used in our study was 
defined as ‘‘any cataract,’’ including mixed cataracts and any subtypes of cataracts. 
 
In these results, we identified 7 significant SNPs associated with diabetic cataract.  
 
The SNP of rs10197646 has the smallest P value of 4.12x10-7, (OR 1.617, 95%CI 1.343, 
1.948), located in the No. 2 Chromosome, with two kinds of allele, G/A; Allele A is the 
Ancestral one. (124). This SNP is greatly associated with diabetic cataract in this 
population, and the OR also shows the allele frequency in cases is much higher than that 
in the controls. In our study, the results demonstrated the basic understanding of the 
significant SNPs in our population. Therefore, the information of significant SNPs from 
the 1000 Genome Project Phase 3 was selected as the standardization to compare with the 
SNPs in our project. The 1000 Genomes Project was an international research with the 
goal of, firstly, creating a complete and detailed catalogue of human genetic variations, 
which in turn can be used for association studies relating genetic variation to disease, and 
secondly providing better support of SNP and probe selection for genotyping platforms 
in future studies and the improvement of the human reference sequence (125). The 1000 
Genome Project compares the two alleles’ distribution. In the whole population, the A 
allele is 38.7%, and the G is 61.3%, where there is a clear difference between them. Then, 
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if we look at the European population, the distribution changes with the A allele with 25% 
and G with 75%. When we search the GBR population (British in England and Scotland) 
in the project, it is obvious that the difference is changing dramatically. The percentage 
of G allele is about four times more than that of A allele, (A 17%, G 83%). At this step, 
the distribution shows the distinct distribution of these two alleles adjusted to the different 
population. After allele frequency, the 1000 Genomes Projects also performs the genotype 
frequency as well, which are GG(39.3%), AA(16.7%) and GA(44.4%) in the whole 
population, GG(58.3%), AA(8.3%), and GA(33.4%) in the European population, then 
GG(70.3%), AA(4.4%), and GA(25.3%) in the British population. This suggests that the 
genotypes changing are related to the different race populations, and GG is the dominant 
genotype in the British (Table 4.1). All the results suggest that the G allele is the majority 
in British people. Although the results could not show the alleles’ distribution and 
genotype directly in our studied population, we can still gather some basic information 
for the dominant allele for future studies. In our studied population, the special allele was 
located in the No.2 locus, and its frequency is 0.1374 in cases and 0.0940 in controls 
(Table 3.2).  
 
Besides, in the same 2 chromosome, SNP of rs7582173 (P: 4.30x10-7 95%CI: 1.342, 
1.947) is closer to the rs10197646 SNP, which is suggested to contain the similar function 
with each other. As we found from the SNP database, the rs7582173 SNP includes Allele 
G/A as well, and with the same Ancestral A allele (126). The population genetics between 
standard 1000 Genomes Project and our studied project could tell us the allele frequency 
for G and A are the same for the whole population and sub-population (Table 4.1). When 
looking at our population (Table 3.2), we could see a slight difference, where the special 
allele has the same frequency of 0.1374 in cases, but a different frequency of 0.09405 in 
controls. Although compared to the general population, where there is no difference to 
the distribution for G/A between rs10197646 SNP and rs7582173 SNP, our project still 
shows us there is little change for these alleles in a particular group.   
 
The SNP of rs62168795 is the next SNP with a smaller P value of 5.59x10-7 (OR 1.463, 
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95%CI 1.26 1.698) located in the No.2 chromosome, whose allele are T and C, and C as 
the Ancestral allele (127). In the Human Genomes Projects’ database, two kinds of allele 
distribute as 16.1% for T allele and 84.9% for C allele. The distribution of T and C alleles 
are equal in the European population, but the frequencies change dramatically in the 
British population, namely T is 72% and C is 28%, which are opposite to the general 
population. When we look at the genotype frequency, the results demonstrate 7.9% of TT, 
75.7% of CC, and 16.4% of TC in the whole population. In the European population, the 
frequency of the three genotypes is similar, TT 13.8%, CC 31.2% and TC 37%. The 
British people have the highest percentage with TT 53.8%, CT 36.3% and CC is only 
9.9%. (Table 4.1) All the results show the T allele is dominant in the British population. 
As for the population we studied, the frequency of the dominant allele is 0.2355 in cases 
and 0.1773 in controls. The difference between them is smaller, which could mean this 
kind of allele is common in general people (Table 3.2). 
 
The SNP of rs1381015 has 7.12x10-7 (OR 1.42, 95%CI 1.236 1.63) significant value in 
the population, which locates in the No.4 chromosome with A/C allele (Ancestral allele 
A) (128). Compared to the Human Genomes Projects’ database, allele A is 87.3% and 
allele C is 12.7% for the whole population. For European people, allele A decreases to 
75.6%, meanwhile, allele C increases to 24.4%. Similarly, these two types of alleles’ 
distribution are stable in England and Scotland population (A 74.2%, C 25.8%). As for 
the genotype, allele A is the dominant allele in all genotype. The whole population 
genotype consists of 76.8% of AA, 21.1% of CC and 2.1% of AC (Table 4.1). The 
genotype in the European and British population are similar. In our population, the 
frequency of the dominant allele is closer in cases (0.2916) and in controls (0.233) (Table 
3.2). 
 
The rs2269547 SNP is associated with the particular disease in our project with 7.25x10-
7 (OR 1.809, 95%CI 1.431 2.288). This SNP was defined in No.22 Chromosome with 
alleles G/C (Ancestral G) (129). In the 1000 Genomes Project Phase 3, the frequency of 
G (88.8%) allele is much higher than C (11.2%) in the whole population. We also found 
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that the distribution of the two kinds of alleles in the European and British population are 
similar to the whole population. Even the allele G has become 90.3% in England and 
Scotland, which suggests that most British people hold single G allele. This frequency 
also has an influence on the distribution of genotypes. According to the huge difference 
between allele G and C, it is obvious that there are only GG (81.3%) and GC (18.7%) 
genotypes in the British population. However, for the European population and whole 
population, the three kinds of genotype are similar to each other (Table 4.1). When looking 
at the population, the frequency of dominant alleles in cases (0.1135) is higher than that 
in controls (0.06675), which suggests the particular allele expresses more on the diabetic 
cataract patients (Table 3.2).  
 
The last associated SNP is rs523355 locating in No. 2 Chromosome, with P value of 
8.63x10-7 (OR 2.149, 95%CI 1.585 2.915), the odd ratio for this SNP is greatest among 
them, which suggest the highest frequency in cases. Compared with 1000 Genomes 
Project Phase 3, this SNP is related to allele G and C (Ancestral G) (130). In the general 
population, we could easily find the majority allele is G (90.8%), allele C has only 9.2 
percent. At the same time, the genotype of the whole population is made up of GG 
(82.9%), CC, (1.2%) and GC (15.9%), which supports allele G being the dominant one. 
In the European population, allele G (93.1%) is still much higher than allele C (6.9%), 
and the CC genotype falls to 4%. When looking at British people, there are only GG 
(90.1%) and CG (9.9%) genotypes. We might conclude that allele G is dominant in 
English and Scottish population (Table 4.1).   
 
The SNP Chr13:48026216:D seems to be discovered recently, because there is no 
information about it in the SNP database. Therefore we still need more researches to 
identify the population genetics about this SNP.   
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Table 4.1: Population genetics allele frequencies from 1000 Genomes Project Phase 3 
Population Allele: frequency  Genotype: frequency 
rs10197646    
All G: 0.613 A: 0.387  G|G: 0.393 A|A: 0.167 A|G: 0.440 
EUR G: 0.750 A: 0.250  G|G: 0.583 A|A: 0.083 A|G: 0.334 
GBR G: 0.830 A: 0.170  G|G: 0.703 A|A: 0.044 A|G: 0.253 
rs7582173       
All G: 0.613 A: 0.387  G|G: 0.393 A|A: 0.167 A|G: 0.440 
EUR G: 0.750 A: 0.250  G|G: 0.583 A|A: 0.083 A|G: 0.334 
GBR G: 0.830 A: 0.170  G|G: 0.703 A|A: 0.044 A|G: 0.253 
rs62168795       
All T: 0.161 C: 0.839  T|T: 0.079 C|C: 0.757 C|T: 0.164 
EUR T: 0.503 C: 0.497  T|T: 0.318 C|C: 0.312 C|T: 0.370 
GBR T: 0.720 C: 0.280  T|T: 0.538 C|C: 0.099 C|T: 0.363 
rs1381015       
All A: 0.873 C: 0.127  A|A: 0.768 A|C: 0.211 C|C: 0.021 
EUR A: 0.756 C: 0.244  A|A: 0.573 A|C: 0.368 C|C: 0.060 
GBR A: 0.742 C: 0.258  A|A: 0.571 A|C: 0.341 C|C: 0.088 
rs2269547       
All G: 0.888 C: 0.112  G|G: 0.793 C|C: 0.018 C|G: 0.190 
EUR G: 0.883 C: 0.117  G|G: 0.779 C|C: 0.014 C|G: 0.207 
GBR G: 0.907 C: 0.093  G|G: 0.813 C|G: 0.187  
rs523355       
All G: 0.908 C: 0.092  G|G: 0.829 C|C: 0.012 C|G: 0.159 
EUR G: 0.931 C: 0.069  G|G: 0.867 C|C: 0.004 C|G: 0.129 
GBR G: 0.951 C: 0.049  G|G: 0.901 C|G: 0.099  
 
All: whole population EUR: European GBR: British in England and Scotland 
 
Based on the SNP database, the rs10197646 and rs7582173 are related to the MAP3K19 
gene (official name mitogen-activated protein kinase kinase kinase 19), also known as 
SPS1/STE20-Related Protein Kinase YSK4; YSK4 Sps1/Ste20-Related Kinase Homolog; 
RCK; YSK4 (131). The MAP3K191 gene is a protein coding gene with related function of 
transferase activity, transferring phosphorus-containing groups and protein tyrosine 
kinase activity (131). The protein coded by this kind of gene originally belongs to the 
Mitogen-activated protein kinase, which are involved in directing cellular responses to a 
diverse array of stimuli, such as mitogens, osmotic stress and heat shock and 
proinflammatory cytokines. They regulate cell functions including proliferation, gene 
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expression, differentiation, mitosis, cell survival and apoptosis (132). This kind of 
function may influence the process of cataract formation.  
 
Recent findings in genome-wide association studies have enabled us to identify thousands 
of genetic variants that are associated with human diseases. In a previous GWASdb SNP-
Disease Associations providing comprehensive functional annotations for each genetic 
variant, including genomic mapping information, regulatory effects, amino acid 
substitutions, evolution, gene expression and disease associations to classify these GVs 
according to diseases using Disease-Ontology Lite and Human Phenotype Ontology (133). 
Researchers tested the database with the significant value between at least 5.0x10-8 and 
1.0x10-5 (134) in a GWAS study; the results showed that there are many related 
association between MAP3K19 gene and diseases that may influence the diabetic cataract 
(133).  
 
Cataract was the first priority we wanted to look at, but there is no direct evidence to the 
association between cataract and MAP3K19 (135). Then in the GWASdb SNP-Disease 
Associations dataset, there are 3,604 genes associated with diabetes mellitus including 
MAP3K gene family, which may influence the development of cataract (133, 136). 
Persons with diabetes mellitus have been found to be at an increased risk of developing 
cataracts when compared with non-diabetic persons (85). In the sugar cataract formation, 
the intracellular increase of sorbitol leads to osmotic changes resulting in hydropic lens 
fibers that may degenerate and form sugar cataract (137, 138). Therefore, in this Osmotic 
hypothesis sugar cataract formation, aldose reductase mediated accumulation of polyols 
results in lens swelling leading to the development of cataract ultimately (3). Furthermore, 
there are other studies showing that osmotic stress in the lens caused by the diabetes 
induces apoptosis lens cells (139) that leads to the cataract (140).  
 
Moreover, hypertension is associated with the MAP3K gene set from the GWASdb SNP-
Disease Associations dataset (133, 141). In a cataract risk factors study in black 
population, the evidence proved that the hypertension is associated with the increased risk 
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of the development of cataract (142). Hypertension is a long term medical condition in 
which the blood pressure in the arteries is persistently elevated (143). Hypertension is 
usually classified as either primary (essential) hypertension or secondary hypertension 
(144); about 90–95% of cases are primary due to nonspecific lifestyle and genetic factors 
(144, 145). However, in our study, the general Caucasian population was analyzed to see 
what may cause the genetic difference when compared with black population. In this 
GWAS study, MAP3K19 gene was defined to be associated with eye problems including 
Myopia and Age Related Macular Degeneration (146).  
 
Myopia, a condition of the eye where light focuses in front instead of on the retina (147), 
causes distant objects to be blurry while close objects appear normal. Severe myopia was 
proven to increase the risk of cataracts (148). In a prevalence of cataract with high myopia 
in an Indian population study, the significant association between high myopia and 
nuclear cataract was established (OR: 3.8, 95% CI 2.9 5.2, P <0.001) (149), which is 
similar with The Blue Mountains Eye Study’s observation (OR: 3.3%; 95% CI 1.5 7.4, P 
<0.001) (150). It declared that nuclear cataract was strongly associated with axial myopia, 
and the density of the nuclear cataract was higher in subjects with myopia (149). Also, 
several population-based studies among adults of different ethnicities offered strong 
evidence to support there is an association between nuclear cataract and myopia (151, 
152).  
 
Age-related macular degeneration (AMD) may result in blurred or no vision in the center 
of the visual field (153), which shows no symptoms at the early stage, however some 
people experience a gradual worsening of vision that may affect one or both eyes over 
time (154). Macular degeneration typically occurs in the older population, and genetic 
factors play an important role in the development that was defined in the GWASdb SNP-
Disease Associations study (133). The severity of AMD is divided into early, intermediate 
and late types (154). The late type is additionally divided into dry and wet forms, and it 
is conformed to be one of the most common reason of blindness after cataract (155). In 
the Health and Nutrition Examination Survey, cataracts and macular degeneration may 
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compromise visual function in older Americans, for persons aged 65 to 75 years old, the 
incidence of cataract and macular degeneration both rise 3 or 4 times, which suggests 
there is an interaction between cataract and macular degeneration in the elderly (54). On 
the other hand, a cross-sectional study showed that cataract surgery was associated with 
increased prevalence of late AMD adjusting for age, race and sex. Furthermore, having a 
severe cataract in the eye was also associated with a slightly higher prevalence of late 
AMD (156). All of these studies supported the association between cataract and age-
macular degeneration.  
 
According to the Gene data (130), rs523355 SNP is on the CCT7 gene, whose official 
name is chaperonin containing TCP1 subunit 7, also known as Nip7-1, TCP1ETA, NIP7-
1, Ccth, CCTETA, CCTH. All of these synonyms will make it easy to look for the new 
findings for this gene in other studies. This gene belongs to the Heat shock protein family 
coding gene, which encodes a molecular chaperone that is a member of the chaperonin 
containing TCP1 complex (CCT), also known as the TCP1 ring complex (TRiC). This 
consists of two identical stacked rings, each containing eight different proteins. Another 
molecular function is that this genes can assist the folding of proteins upon ATP 
hydrolysis including actin and tubulin (157, 158). According to the gene expression 
database, as one of the heat shock protein encoding genes, CCT7 expresses highly in the 
lens of camera-type eye in the human (159). The eye of the human being is similar to an 
adult lamprey, which possesses numerous features that are very similar to those of the 
eyes of jawed vertebrates. The lamprey's camera-like eye has a lens, an iris and extra-
ocular muscles lacking intra-ocular muscles. Its retina also has a structure very similar to 
that of the retinas of other vertebrates, with important function cells in three nuclear layers 
(160). Additionally, the southern hemisphere lamprey possesses five morphological 
classes of retinal photoreceptor and five classes of opsin, each of which are closely related 
to the opsins of jawed vertebrates. Comparing these similarities, the expression of this 
gene affects transparent eye structure, which is the key point in the progress of cataract 
formation (160). In another investigation to test the physiological function of αA-
Crystallin in lens cells, αA knock-out mouse lens epithelial cells and human lens epithelial 
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cells that over express αA were exposure in the high level of UV light, after four-hour 
exposure, The growth rate of αA(−/−) mouse lens epithelial cells was reduced by 50% 
compared with cells with αA. As a member of the small heat shock protein (sHSP) family, 
molecular Chaperone αA-Crystallin was found to enhance lens epithelial cell growth and 
resistance to UVA stress(161) (162). At the same time, the loss of molecular Chaperone 
αA-Crystallin was shown in the human lens at older age, which is likely to cause 
development of cataract with age-independent increase (163). Therefore, the expression 
of CCT7 gene molecular Chaperone αA-Crystallin in human lens will affect the 
development of cataract at some point. Besides, we found that the CCT7 gene has 
expression on human blood, kidney function, and Proteinuria, which all have different 
influence on the development and progress of cataract (133).  
 
Based on the Geneview (164), the rs62168795 SNP is related to the R3H domain 
containing 1 gene, also called R3H domain containing 1, which encodes R3H domain-
containing protein 1 protein. This kind of protein contains function of poly (A) RNA 
binding, interacting non-covalently with a poly (A) RNA, but there is no direct connection 
between this molecular function and cataract. If we search more about R3HDM1 gene 
expression in the human cells’ from previous experiments, we find this gene might 
express on the function of kidney, cardiovascular system, adipose tissue and so on (165). 
Instead, we found evidence showing that this gene expresses in the epithelium of lens 
(166) in the other animals. The experiment proved that apoptosis of lens epithelial cell 
could occur under the various stress factors including oxidative stress, UV and other toxic 
agents (140). There is a great deal of evidence the supports the death of the lens epithelial 
cells via apoptosis can lead to cataractogenesis. Firstly, the death of lens epithelial cells 
will disturb the lifelong growth of the lens, leading to the thinness of cataract lenses (167, 
168) and the decreased density of epithelial cells in the cataract lenses (169, 170). Then, 
the elimination of homeostatic epithelial cell control of the fiber cells often occur when 
lacking patches of lens epithelial cells, which caused the impairment of the integrity and 
transparency of these fiber cells (171). These processes eventually enhance the 
aggregation of crystalline (172) related to development of cataract (173, 174). As a matter 
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of fact, this gene expression is on the rat lens for now, however there is still a connection 
because the structure of the lens system is similar between human and rats. In future, we 
need more studies to find the evidence of the expression of R3HDM1 gene in human lens 
 
The last gene we described is GGA1, with official name of Golgi-associated, gamma 
adaptin ear containing, ARF binding protein 1, which is related to the rs2269547 SNP. 
This gene encodes a member of the Golgi-localized, gamma adaptin ear-containing, ARF-
binding (GGA) protein family (175). Members of this family are ubiquitous coat proteins 
that regulate the trafficking of proteins between the trans-Golgi network and the lysosome. 
These proteins share an amino-terminal VHS domain which mediates sorting of the 
mannose 6-phosphate receptors at the trans-Golgi network (176). In an early study, the 
trans-Golgi network was related to calcium activity in the human system. The Golgi 
apparatus is an established calcium store (177, 178), and its role in sorting and processing 
secretory and membrane proteins is highly sensitive to changes in calcium concentration 
within the lumen. Recent experiments performed show that calcium gradients across the 
Golgi play a fundamental part in intracellular calcium signaling and homeostasis (178). 
Furthermore, the calcium channel is expressed and distributed in the epithelium and 
cortical fiber cells in the mouse lens (179). The different levels of calcium have been 
reported to induce progressive cortical cataract formation and are associated with 
decreased lens weight in ex vivo mouse lenses (179). Meanwhile, blocking of calcium 
exchange will cause the proliferation of human lens epithelial cells (180), and researchers 
have confirmed there was more than a 23-fold increase in total lens calcium with cataract 
(181). Therefore, all of these studies show there is a connection between our special gene 
and calcium activity in the human lens; we could conclude this gene’s expression will 
influence the development of cataract formation to some degree. Besides, this gene also 
expresses on the lens of camera-type eye, the function of which has been discussed. 
 
Apart from the genes mentioned above, there are still two significant SNPs, 
chr13:48026216:D and rs1381015, we could find the related genes form SNPs database. 
In the future, we need further studies to search wider SNP database to locate the related 
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genes and find out the potential association among them.  
 
4.2. Epidemiology Discussion 
Now we will examine the findings according to the epidemiological results to 
demonstrate the association between genetic variants and characteristics of population. 
 
In our epidemiological study, the prevalence of diabetic cataract is 36.7%, and we used 
the age adjusted to the population of Tayside based on the census of Scotland Health 
Board Area 2011, to calculate the age-adjusted prevalence of cataract as 24.9% (Table 
3.5). The Tayside prevalence of cataract is higher than the age-adjusted prevalence, which 
suggests that the age is a strong significant factor to the diabetic cataract, and in our 
studied population, the prevalence of cataract is increasing with the rise of age, but the 
prevalence in age group over 75 has fallen. The past study to estimate cataract prevalence 
for 24,409,978 people in the United States age 40 and older, shows the prevalence in 
different races all follow the basic tendency that increase straight to over 80 years old 
(182). Although the highest prevalence of cataract is in the group of 60-74 years old in 
our study, the percentage of cataract people still increases with the rise of age in the 
population (Figure 3.2). In the North London Eye Study’s evidence, the prevalence of 
visually impairing cataract rose steadily with age: 16% in the 65 to 69 year age group, 
24% in people of 70 to 74 years of age, 42% in those 75 to 79 years of age, 59% in those 
80 to 84 years, and 71% in people of 85 years or more (51). And in our report, we could 
notice the result for age in Figure 3.2 and Table 3.14 are not consistent. We already 
discussed that early study confirmed the risk of diabetic cataract would increase with the 
rise of age (Table 3.2). However, the age in table 3.14 showed the different result, 
According to my statistical analysis, I used the Enter method to force all variables into 
the regression model to analyze without considering the contribution of each variables 
confounding others, which might mislead the real association between risk of diabetic 
cataract and each factor we chose. 
 
Additionally, a follow-up study shows the estimate of cataract prevalence is likely to rise 
57 
 
 
with age in general, according to the Beaver Dam Eye Study (183), although we did not 
offer the prevalence of subtypes in our study like the Beaver Dam Eye Study did. Then, 
in the multivariate regression model, we found that the odd ratio for age seems to be less 
than 1 (0.955), which might explain the decline of cataract prevalence from the group 60-
74 to the group over 75. In conclusion, growing age is the most common risk factor (114), 
lens proteins denature and degrade over time, and this process is accelerated by diseases 
such as diabetes mellitus (184). 
 
Another key factor related to the age-specific cataract prevalence is the duration of 
diabetes, which was not analyzed in our study. As the significant risk factor for cataracts 
in diabetic patients, the longer duration of diabetes would indicate the higher incidence 
of cataract (90). A further 2 year follow-up in The Blue Mountains Eye Study showed 
that diabetic patients with longer than 10 years disease had higher Relative Risk (3.3) to 
develop the cataract in the future (185). The reason we did not include the duration of 
diabetic is that we excluded diabetes cases with incomplete cataract information during 
the data processing. In actual health records, patients with a shorter diabetes history were 
less likely to develop cataract, those who had no cataract tended to have an incomplete 
cataract record. As a result, the total number of shorter diabetes duration cases was 
smaller compared to cases for longer diabetes duration; many shorter diabetes duration 
cases without cataract were not included. Like the results in previous studies, stronger 
associations for the shorter period may be expected if the association is attributable to the 
effects of poor vision because the level of visual impairment present at the time a fracture 
would be much better reflected by a recent eye examination than one performed many 
years in the past. It is possible that frailer individuals, and those with more severe diabetes, 
were more likely to die before the end of follow-up, which could have attenuated this 
effect (185). 
  
Gender is another key associated factor for diabetic cataract. The cataract prevalence of 
women was 39.2% when compared with 34.4% of men. In the any cataract group, the 
percentage of female is still higher than that of male. (Table 3.4) Similarly, the studies for 
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cataract prevalence in the United States and Australian population, state that women had 
the higher cataract prevalence than men (55, 59), and the relative risk of female compared 
to male (RR: 1.14) also suggests that women suffer more risk of developing cataract than 
men in our population. Moreover, the previous U.S. study with eHealth records that is 
similar to our data records, showed the prevalence of cataract by gender in different age 
groups (186) where the cataract prevalence of female is higher than the prevalence of 
male. Latest years’ work have already proved that the females have a higher incidence of 
cataract than the males, and the prevalence as well (187, 188). In fact, our study offered 
similar cataract prevalence by gender in the age groups, although the prevalence for 
females is lower than that of male in group of 30-44, the possible reason might be that we 
excluded the patients under 30 years old which caused missing and incomplete data.  
 
Smoking and alcohol are analyzed to have significant association with diabetic cataract 
separately. However, alcohol intake was proven to non-significant with diabetic cataract 
in multivariate regression. As a risk factor for diabetic cataract, current smoking cases 
(OR: 1.313 95%CI: 1.034 1.667) are more than that of controls as based on the tables 
shown (Table 3.14). A review of the evidence revealed that smoking increases the risk of 
a particular type of cataract – nuclear cataracts. (189, 190). Smokers who tend to consume 
20 or more cigarettes per day, are at least twice as likely to develop a nuclear cataract 
compared to never smokers (74). A smoker’s risk of developing cataract increases with 
the amount smoked; cataracts are more severe in heavy smokers than in light smokers (89, 
191). Another important finding is that ex-smokers are more than current smokers for 
cases and controls groups in our study (Figure 3.4). A follow-up study lasting 12 years 
found current smokers of more than 15 cigarettes per day had a 42% increased risk of 
cataract extraction (OR:1.42, 95% CI, 1.28-1.58) compared with never smokers after 
adjustment for age and other potential risk factors. After more than 20 years since 
stopping smoking, these people had a 21% increased risk of cataract extraction (OR: 1.21, 
95% CI, 1.06-1.39) compared with never smokers (192), which claimed smoking 
cessation significantly decreased the risk for cataract extraction with time (P<0.001). The 
higher the intensity of smoking, the longer it takes for the increased risk to decline, but 
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we did not collect the intensity of smoking for current smokers and ex-smokers, this could 
be discussed in any future study.  
 
As for alcohol, the regression showed it is a non-significant factor for diabetic cataract 
(Table 3.14), because we use the UK government alcohol intake guideline to define the 
new variable, which might affect the association between alcohol and risk of diabetic 
cataract. Recent work by a team from Boston University found that heavy consumption 
of alcohol seriously increased the risk of having cataract surgery. Moderate consumption 
of alcohol seemed to correlate to reduced odds of surgery (193). The most important part 
is that an adverse effect of alcohol was stronger among smokers, people who smoked and 
drank heavily had an increased prevalence of nuclear cataract (194).  
 
Our study demonstrated BMI is related to diabetic cataract, and the average BMI in our 
groups is 31.27 (non-cataract) and 30.64 (any cataract). According to the WHO BMI 
classification, the normal range is 18.50-24.99 (116), a person with BMI over 30 belongs 
to the obese group. Besides, if we look at the distribution of people in different BMI 
groups, we discover that 24.1% of cases in under the 27.70 group and 34.4% of cases are 
in the 27.70-31.32 group; which might suggest almost half of diabetic cataract patients 
are in the normal BMI range. The Framingham longitudinal studies using the Taylor and 
West lens grading system suggested that higher levels of average BMI and increasing 
BMI over time were risk factors for cortical opacity. Increasing BMI over time was also 
associated with posterior subcapsular opacity (195, 196). When looking at the different 
ranges of BMI, the results showed that only range (27.70-31.32) was significant with 
diabetic cataract, which is a protective factor as well (OR:0.838, 95%CI: 0.703 0.998) 
(Table 3.14), although other ranges are non-significant, their odd ratio are all over 1. A 
survey (101) on Chinese adults in Tanjong Pagar of Singapore showed lower BMI was 
associated with cortical cataract and any cataract.  
  
Compared with relationship between risk of nuclear opacity and body mass index from 
the Shihpai Eye Study, we could easily find there is a similar odd ratio as ours. As a 
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protective factor in our study, the patients in range of 27.70-31.32 should have been less 
than other ranges’, on the contrary, the percentage of any cataract in the lower range is 
higher than those in other ranges in our study. The possible reason could be that there is 
classification in our study. We should not miss that the previous studies use the LOCIII 
system to classify the cataract patients as nuclear, cortical and posterior subcapsular. The 
figure only showed the relationship between nuclear cataract and BMI, so if we put all 
subtypes into the model in future research, the results may be different. All in all, our 
study, combined with recent works, support that BMI is an independent risk factor for 
cataract (195). 
 
We also included social economic factors in our regression model which appeared to be 
very interesting, SIMD score was used to measure deprivation level and it incorporated 
seven different aspects (employment; income; health, education, skills, and training; 
geographic access to services; crime and housing) of deprivation, combining them into a 
single index. SIMD score was based on ranking within a certain area (120). The SIMD 
scores we used were within the Tayside Health Board area and Scotland. The previous 
studies presented that more deprived populations have a higher risk of developing cataract 
(197). The logistic regression result showed that the affluent group (OR: 0.842) and most 
affluent group (OR: 0.995) in the Tayside area were protection factors for cataract (Table 
3.14). Reports from the WHO Commission on Social Determinants of Health have 
emphasized the link between social and health inequalities, lower socioeconomic status 
has been shown to be associated with a higher risk of eye health (198, 199). The affluent 
people are able to have access to better healthcare to prevent cataract, even they can carry 
the cataract surgery at early state of disease, which will reduce the prevalence of cataract 
(199). While we should also focus on relatively rich groups with 95%CI including 1, this 
could still be a risk factor for diabetic cataract in this study. The possible explanation 
could be that rich people had higher chance of being outside for vacation and had higher 
VU light exposure. Another possible factor to be considered is that the Tayside area 
includes the sunniest places in Scotland, where the average is about 1,500 hours per year, 
which is more than average in any other places (maximum 1,300 hours per year) in 
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Scotland (200). Consequently, people in the sunniest places tend to protect themselves 
from being exposed in the strong UV light damage that is recognized as a potential risk 
factor of cataract. But we still need more studies to explain the reason for relatively 
affluent in Tayside area as a protect factor. 
 
Next, we would like to talk about the biochemistry factors in the study. The univariate 
and multivariate analysis offered 5 identified variables as potential risk or protective 
factors for diabetic cataract (Table 3.14). There were no clear cut diagnose standard for 
Hypertension, thus the only cardiovascular related variable in our study was blood 
pressure (diastole and systole). Based on a prospective study of blood pressure and risk 
of cataract, there is no strong association between cataract and blood pressure, which is 
subject to confounding by multiple risk factors (201). Moreover, latest findings referred 
that cataract and systolic blood pressure were significantly associated, but not with 
diastolic BP (202). According to our results, the systolic blood pressure was a protective 
factor (OR: 0.997), which would decrease risk when systolic blood pressure rises. 
Oppositely, the diastolic blood pressure was shown to be the risk factor for diabetic 
cataract (OR: 1.004) (Table 3.14) . As a matter of fact, the average blood pressure (diastole 
and systole) in our population was higher than the desired blood pressure levels (Table 
3.3), which is recognized as hypertension. Basically, hypertension could be recognized as 
the significant factor to cataract in previous studies (142). Under this circumstance, the 
cataract people seem to decrease with the rise of systolic blood pressure. As for diastolic 
blood pressure, it is a risk factor in our study (OR: 1.003), which would increase the risk 
of diabetic cataract.  
 
As for three related variables, total serum cholesterol, serum HDL cholesterol and serum 
LDL cholesterol, our results showed that higher total serum cholesterol (2nd )seemed to 
decrease the risk of cataract (OR: 0.798, 95%CI: 0.642 0.992), then the serum HDL 
cholesterol is also a protective factor for diabetic cataract, because the 3rd quartile is 
strongly associated with diabetic cataract (OR: 0.737, 95%CI: 0.596 0.910 ), the LDL 
cholesterol is not significantly associated with the development of cataract in this study 
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though (Table 3.14). In many epidemiological studies, it has been suggested that, in 
different contexts, cholesterol may act as an antioxidant in the lens (203, 204). In our 
study, the higher total serum cholesterol could be considered as a protective factor. On 
the other hand, the high LDL cholesterol presents significant cataractogenic risk factors 
(89), but the lens is supported to be protective by the high serum HDL cholesterol (205), 
and the low LDL: HDL ratio also could decrease the risk of cataract in patients (205). 
However, we cannot find this possibility for HDL and LDL in our study, which might be 
due to the lack of whole study population’s biological test.  
 
The serum triglycerides are analyzed to have the possibility to prevent the development 
of diabetic cataract in higher level in our study. The distribution of cases in the higher 
serum triglycerides group also shows the same results that few cataract patients in higher 
serum triglycerides. The higher serum triglycerides could raise the risk of heart disease 
and stroke (206, 207) for the studied people, which would lead the death or incomplete 
health records. Unlike our study, the Framingham Study showed an association between 
elevated serum triglycerides and posterior cataract (98, 208). These differences in risk 
factors, among the different populations, can be related to the different genetic patterns 
associated with different types of cataract. We couldn’t find accurate results about the 
association without the classification for the cataract in our study.  
 
The limitation of the study was our inability to subtype the cataract groups firstly, which 
might invalidate some causal relationship between risk factor and cataracts, or miss the 
potential risk factors. Secondly, the wider population of Scotland was not taken into 
account. The SNPs were only collected in Tayside population from GoDARTs, which 
caused that we couldn’t get more significant P value (5x10-8) in our project.  Then, our 
case definition includes all cataract patients with one or both eyes and patients with 
cataract extraction, we did not consider the prevalence of extraction and prevalence of 
cataract with one eye and that with both eyes, which could cause statistical error in our 
analysis. Although, most people will eventually develop a cataract in both eyes, one eye 
may be affected before the other. If taking this into consideration, we could predict that 
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most of the patients with cataract are still in the process of cataract development. Also, 
we used the ENTER to put all variables in to the logistic regression model which didn’t 
consider the contribution of each factor. Over the past decades, rates of cataract surgeries 
have doubled in most of the UK; the current surgical rate approximates to a crude rate of 
6.2 extractions per 1,000 population (11). The comparison with our results will show 
consistent condition for surgery rate, because the surgery may be the only effective 
treatment to cataract for now (11). All in all, further research is necessary to find more 
information about the diabetic cataract in the future. 
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5. Chapter 5. Conclusion 
 
 
The key contribution of our study has two parts including genetic variants and 
epidemiological reports. In genetic variants contribution, we identified 7 significant SNPs 
for diabetic cataract in the Tayside area of the Scottish population with GoDARTs and 
found the related gene containing MAP3K19, R3HDM1, GGA1, and CCT7 that associated 
with the progression of diabetic cataract. The epidemiological report provided the current 
cataract epidemiology status by excavating existing electrical health record. Major figures 
and trends are consistent with older studies in sources of population-based data for the 
prevalence of cataract in the UK, the prevalence of visually impairing cataract rose 
steadily with age (51, 209-212), and we also demonstrated other potential risk factors and 
protective factors of diabetic cataract in Tayside area in Scotland population. 
 
With the established evidence in the fields of genetics, this project could provide more 
understandings about the mechanism of diabetic cataract, and drive us to carry out further 
related studies and functional studies to confirm the roles of more genes as risk factors 
associated with diabetic cataract. With the additional epidemiological reports, we should 
also focus more the preventing and treatment of diabetic cataract including details on the 
diagnostic criteria and guidelines for management in Scotland, and all of the UK. All in 
all, the findings give hopes for the millions of people with diabetes. They will not have 
to fear any possibility of life with visual impairment or blindness due to their illness and 
can live long, healthy, pleasurable, fulfilled lives. 
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7. Appendix 
List of Abbreviated Word 
SNP: Single Nucleotide Polymorphisms 
BMI: Body max index 
WHO: World Health Organization 
GWAS: Genome-Wide Association Studies 
LOCS: Lens Opacity Classification System 
AR: aldose reductase 
STZ: Streptozotocin 
AGE: Advanced glycation end 
GSH: Glutathione  
TCF7L2: Transcription Factor 7-like 2  
RR: Relative risk  
UV-B: Ultraviolet B  
IOL: Intraocular lens implant  
ICCE: Intracapsular cataract extraction  
ECCE: extra capsular cataract extraction  
NHS: National Health Service 
GoDARTs: Genetics of Diabetes Audit and Research Tayside  
SCI-DC: Scottish Care Information-Diabetes Collaboration 
WTCCC2 Wellcome Trust Case Control Consortium 2  
SUMMIT: Surrogate markers for Micro- and Macro-vascular hard endpoints for 
Innovative diabetes Tools  
NHANES: National Health and Nutrition Examination Survey 
SIMD: Scottish index of multiple deprivation  
AMD: Age-related macular degeneration 
 
